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Abstract
Patients with neurological diseases are vulnerable to cerebral ischemia, which can lead to
brain injury. In the intensive care unit (ICU), neuromonitoring techniques that can detect
flow reductions would enable timely administration of therapies aimed at restoring adequate
cerebral perfusion, thereby avoiding damage to the brain. However, suitable bedside
neuromonitoring methods sensitive to changes of blood flow and/or oxygen metabolism have
yet to be established.
Near-infrared spectroscopy (NIRS) is a promising technique capable of noninvasively monitoring flow and oxygenation. Specifically, diffuse correlation spectroscopy
(DCS) and time-resolved (TR) NIRS can be used to monitor blood flow and tissue
oxygenation, respectively, and combined to measuring oxidative metabolism. The work
presented in this thesis focused on advancing a DCS/TR-NIRS hybrid system for acquiring
these physiological measurements at the bedside.
The application of NIRS for neuromonitoring is favourable in the neonatal ICU since
the relatively thin scalp and skull of infants has minimal effect on the detected optical signal.
Considering this application, the validation of a combined DCS/NIRS method for measuring
the cerebral metabolic rate of oxygen (CMRO2) was investigated in Chapter 2. Although
perfusion changes measured by DCS have been confirmed by various flow modalities,
characterization of photon scattering in the brain is not clearly understood. Chapter 3 presents
the first DCS study conducted directly on exposed cortex to confirm that the Brownian
motion model is the best flow model for characterizing the DCS signal. Furthermore, a
primary limitation of DCS is signal contamination from extracerebral tissues in the adult
head, causing CBF to be underestimated. In Chapter 4, a multi-layered model was
implemented to separate signal contributions from scalp and brain; derived CBF changes
were compared to computed tomography perfusion.
Overall, this thesis advances DCS techniques by (i) quantifying cerebral oxygen
metabolism, (ii) confirming the more appropriate flow model for analyzing DCS data and
(iii) demonstrating the ability of DCS to measure CBF accurately despite the presence of a
thick (1-cm) extracerebral layer. Ultimately, the work completed in this thesis should help

with the development of a hybrid DCS/NIRS system suitable for monitoring cerebral
hemodynamics and energy metabolism in critical-ill patients.

Keywords
Near-Infrared Spectroscopy, Diffuse Correlation Spectroscopy, Delayed Cerebral Ischemia,
Cerebral Blood Flow, Cerebral Oxidative Metabolism.
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Chapter 1

1

Introduction

The intention of this introductory chapter is to give a rationale for the experiments that
comprise this thesis entitled: “Digging Deeper with Diffuse Correlation Spectroscopy”.
First, the clinical rationale for developing a non-invasive device to monitor cerebral
hemodynamics in patients in the intensive care unit (ICU) is presented. A description of
current clinical methodologies and their limitations are outlined. This is followed by a
description of a promising optical technique that may overcome some of the caveats of
current methods. The theoretical basis of this optical technique, known as diffuse
correlation spectroscopy (DCS), is provided, and followed by an extensive review of
current applications and limitations of this technology.

1.1 Clinical Rationale
1.1.1

Intensive Care Patients

In 1953, during the polio epidemic, hundreds of patients developed respiratory failure,
requiring emergency tracheotomies. However, typical hospitals at that time had
inadequate resources to accommodate the patient overload. As a result, the first ICU was
established to perform tracheotomies quickly, ultimately reducing mortality (Kelly, Fong,
C, & D, 2014). Generally, an ICU describes a location where critically ill patients obtain
proper care from specialists. Over the past twenty years, the ICU has evolved into
multiple sub-specialty treatment centers, such as the neonatal and neurological ICUs, that
cater towards a particular disease or complication, with the aims of improving patient
outcome and reducing mortality.
Common to both neonatal and neurological ICUs is the concern for maintaining
adequate cerebral blood flow (CBF). Preterm infants make-up a large portion of patients
in the neonatal ICU and their immature cerebral vasculature makes them susceptible to
impaired autoregulation of CBF (Peeples, Mehic, Mourad, & Juul, 2015). Within the
neurological ICU, patients who have experienced a neurological emergency, such as a
stroke (Aries, Elting, De Keyser, Kremer, & Vroomen, 2010), a subarachnoid
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hemorrhage (SAH) (Otite et al., 2014; Washington & Zipfel, 2011), or a traumatic brain
injury (TBI) (Bouma & Muizelaar, 1992; White & Venkatesh, 2008), are vulnerable to
further complications, including cerebral edema, cerebral vasospasm, and impaired
cerebral autoregulation.

1.1.2

Neurological Complications

In patients requiring intensive care due to one of the various neurological emergencies
mentioned earlier, further complications often cause elevated intracranial pressure (ICP)
and a corresponding decrease in CBF. Therefore, the goal of current interventions that
target ICP is ultimately to increase CBF.
A primary concern with ICU patients is cerebral edema, which refers to the
accumulation of excessive fluid in the brain. For instance, mortality for patients with
large hemispheric strokes who have evidence of cerebral edema is up to 80% (Hacke et
al., 1996; Ropper, 1984). Cerebral edema leads to elevated ICP due to volume constraints
within the cranium. In turn, elevated ICP can impair CBF by reducing cerebral perfusion
pressure (CPP), making patients susceptible to secondary ischemic brain injury.
Management techniques to reduce ICP include the administration of hyperosmolar
agents, such as mannitol or hypertonic saline, to promote osmotic flow outward from
brain parenchyma (Singh & Edwards, 2013). Should a poor response be observed, more
aggressive approaches, such as spinal taps and external ventricular drain (EVD) or
decompressive craniectomy, are performed to drain excessive fluid or increase the
volume capacity of the brain, respectively, both of which reduce ICP in order to restore
cerebral perfusion.
Another cause of delayed cerebral ischemia (DCI), which occurs in approximately
60% of SAH patients, is cerebral vasospasm, which is caused by involuntary constriction
of arteries in the brain (Weir, Grace, Hansen, & Rothberg, 1978). Between 20-50% of
SAH patients develop secondary cerebral ischemia (Schmidt et al., 2008), which may
progress into infarcted cerebral tissue. Symptoms of clinical deterioration and newly
formed infarcts trigger the use of interventional strategies, such as administrating the
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vasodilator nimodipine (Macdonald, 2014); however, about one-third develop infarction
due to vasospasm asymptomatically (Schmidt et al., 2008).
The maintenance of CBF over a wide range of systemic blood pressure is
described by cerebral autoregulation (CA). During variations in blood pressure (Figure
1-1), normal CBF is maintained (~50 mL/100g/min) by adjustments to cerebrovascular
resistance (Steiner & Andrews, 2006). However, impairment to CA occurs in about onethird of patients with TBI (Bouma, Muizelaar, Bandoh, & Marmarou, 1992; Muizelaar,
Ward, Marmarou, Newlon, & Wachi, 1989), leaving patients susceptible to CBF
fluctuations during spontaneous changes in systemic blood pressure (Robertson et al.,
1999), and ultimately, these patients are vulnerable to DCI. Similar therapeutic
interventions to those mentioned earlier (i.e. surgical intervention, or administering
hyperosmolar and/or vasodilating drugs) are employed to increase CBF.

Figure 1-1: Cerebral Autoregulation Plateau; adapted from (White & Venkatesh,
2008)

1.1.3

Clinical Management

Currently, there is no standard method of diagnosing DCI (Sanelli et al., 2014). The best
predictor of negative outcome for ICU patients depends on neurological examinations of
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their physical characteristics (Alonso et al., 2015; De Oliveira Manoel et al., 2015;
English et al., 2013; Kirkman, Citerio, & Smith, 2014), such as level of consciousness as
assessed by the Glasgow Coma Scale (Picciolini et al., 2015; Tyson, Parikh, Langer,
Green, & Higgins, 2008). Clinical classification scales can help identify patients who are
vulnerable to DCI, but they lack specificity and sensitivity (Vergouwen et al., 2010).
Patient management would be strengthened by monitoring tools that could detect early,
subtle, functional changes, such as impaired CA (De Oliveira Manoel et al., 2015).
Furthermore, management of stroke patients has been shown to improve outcome and
decrease mortality (Alonso et al., 2015; P. Langhorne et al., 2005) and is especially
important during the early-onset of cerebral edema, which peaks a few days after
infarction (Shaw, Alvord, & Berry, 1959). However, to diagnose the susceptibility of
DCI in patients that are heavily sedated or comatose is not appropriate (Vergouwen et al.,
2010). A continuous bedside assessment of the neurological deterioration would improve
sensitivity for early detection and prevention of DCI.
In general, an ICU with specialized neurointensivists results in better efficiency
and earlier discharge due to improved patient outcome (Bershad, Feen, Hernandez, Suri,
& Suarez, 2008; Diringer & Edwards, 2001; Unit & Collaboration, 2013). Providing the
specialized neurointensivists with proper tools for monitoring neurological deterioration
can further improve patient outcome by aiding in early detection of DCI (Sarrafzadeh,
Vajkoczy, Bijlenga, & Schaller, 2014). One approach for detecting DCI is by measuring
CPP, which is defined as the difference between the mean arterial pressure (MAP) and
ICP. When possible, current clinical management techniques detect low perfusion by
monitoring a surrogate physiological parameter of perfusion, ICP, since common
neurological complications result from elevated ICP. In adults, ICP is normally between
7-15 mmHg, with pressures greater than 20 mmHg considered neurologically significant
(Bratton et al., 2007). This would enable the intensivist team to determine if CBF falls to
ischemic levels, which is typically defined as values below 15 mL/100g/min (Symon,
Branston, Strong, & Hope, 1977). However, specific pressure thresholds presented in the
literature have been inconsistent (Steiner & Andrews, 2006), suggesting that a method of
directly measuring CBF would assist in the management of neurological emergencies.
Early detection of low blood flow would provide the opportunity to administer
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therapeutic treatments to restore CBF in order to prevent secondary brain injury (Coles et
al., 2002; Surgeons., 2007).
In addition to monitoring CBF, measuring the cerebral metabolic rate of oxygen
(CMRO2) could help identify clinically significant blood flow reductions, i.e. decreases
that exceed the compensatory increase in oxygen extraction. This is demonstrated in
Figure 1-2, which shows the reduction in CMRO2 that occurs when the increase in the
oxygen extraction fraction (OEF) is not sufficient to match the drop in CBF (Dhar et al.,
2012; Powers, Grubb, Darriet, & Raichle, 1985; Vespa et al., 2005). For example, in
SAH patients, DCI is directly related to poor outcome (Vergouwen, Ilodigwe, &
MacDonald, 2011); however, cerebral infarction can occur without any observable
symptoms during normal pressure levels (Chen et al., 2011; Schmidt et al., 2008).
Insufficient oxygen delivery to brain tissue results in failing ion pumps and deficiencies
of energy required for cell survival (Boas & Franceschini, 2011; Powers et al., 1985).
However, there is no ideal monitoring device of perfusion/metabolism at the bedside (Le
Roux, 2013).
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Figure 1-2: Stages of hemodynamic impairment as cerebral tissue perfusion fails; adapted
from (Dhar & Diringer, 2016)

1.2 Neuromonitoring Methods
1.2.1

Invasive Techniques

An important aspect of intensive care practice is monitoring ICP, which requires inserting
an invasive fiberoptic probe into the brain parenchyma or a catheter into the
intraventricular space. Elevated ICP is associated with the incidence of secondary
ischemic brain injury as well as worse clinical outcome (Andrews et al., 2002; Juul,
Morris, Marshall, & Marshall, 2000). Therefore, increased ICP indicates to a
neurointensivist to administer therapeutics designed to improve CBF; however,
observational studies question the benefits of monitoring ICP (Cremer et al., 2005; Shafi,
Diaz-Arrastia, Madden, & Gentilello, 2008). It could be argued that this is not
unexpected since ICP is only a surrogate marker of perfusion and that variations in
cerebral vascular resistance could alter the relationship between the two.
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Rather than monitoring ICP, cerebral perfusion can be measured by inserting laser
Doppler flowmetry (LDF) or thermal diffusion flowmetry (TDF) probes directly into
brain parenchyma. The former is a well established technique for real-time flow
monitoring; however, it only measures relative flow changes. Although technically
challenging, TDF provides quantitative measurements of local cerebral perfusion and has
been shown to detect CBF changes associated with vasospasm (Vajkoczy, Horn, Thome,
Munch, & Schmiedek, 2003).
In addition to flow monitoring, cerebral microdialysis (CMD) probes provide the
capability to measure the biochemistry of tissue (Tisdall & Smith, 2006). In particular, an
increase in the lactate/pyruvate ratio (LPR) has proven to be a reliable biomarker of tissue
ischemia (Ståhl, Mellergård, Hallström, Ungerstedt, & Nordström, 2001). Also, brain
tissue oxygen tension (PbtO2) can be measured by a Clark electrode. In TBI and SAH
patients, PbtO2 monitoring has been shown to improve outcome compared to
management based on ICP monitoring (Narotam, Morrison, & Nathoo, 2009;
Ramakrishna et al., 2008). However, in an ischemic stroke population, approximately
half of the patients who were treated for elevated ICP showed changes in the jugular
venous oxygen saturation that did not reflect concurrent CBF measurements (i.e.
oxygenation remained unchanged when CBF was altered, and vice versa), despite finding
reductions of both parameters in non-survivors (Keller, Steiner, Fandino, Schwab, &
Hacke, 2002). This suggests that monitoring jugular bulb oximetry alone should be
interpreted with caution and highlights the importance of supplementing oxygenation
values with a direct measurement of CBF to determine the efficacy of therapeutic
treatments.
Despite the ability of each technique to monitor a key physiological parameter at
the bedside, all such devices are highly invasive since they require inserting a probe
directly into the tissue. Invasive probes/catheters increase the risk of hemorrhage and
ventriculitis (Narayan et al., 1982; Pfausler et al., 2004); the latter is susceptible to higher
risk from repetitive catheter insertions (Arabi et al., 2005). Furthermore, these invasive
techniques are limited to assessing a small tissue volume (~1 mm3) near the location of
the probe. Due to their invasive nature, the use of these methods is typically restricted to
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severe brain-injured patients. Nevertheless, the sensitivity of these methods to impaired
CBF and energy metabolism highlights the potential value that non-invasive monitoring
methods could provide to neuro-intensive care.

1.2.2

Transcranial Doppler Sonography

A non-invasive technique, known as transcranial Doppler (TCD), has proven to be
valuable for diagnosing and monitoring cerebral vasospasm (Sekhar, Wechsler, Yonas,
Luyckx, & Obrist, 1988), a known precursor to secondary brain injury in SAH patients
(Connolly et al., 2012; Staalsø, Edsen, Romner, & Olsen, 2013). Principally, TCD is used
to measure flow velocities in the middle cerebral artery (MCA) (Sloan et al., 2004;
Washington & Zipfel, 2011), which supplies ~80% of hemispheric blood flow (Moore,
David, Chase, Arnold, & Fink, 2006). In the MCA, vasospasms are identified by TCD
with a high specificity (94-100%) but moderate sensitivity (38-91%), and its application
to other cerebral arteries has proven less accurate (Lee et al., 2006; Washington & Zipfel,
2011). Arterial blood flow velocities are related to perfusion in the macro-vasculature,
and therefore, TCD velocity measurements do not reflect micro-vascular perfusion. This
suggests a means to directly measure CBF would be beneficial, especially for detecting
and monitoring secondary cerebral ischemia, since presence of vasospasms does not
solely contribute to cerebral infarction and neurological worsening (Vergouwen et al.,
2011).

1.3 Near-Infrared Spectroscopy
The work completed in this dissertation is driven by the current lack of a means of
measuring CBF in the clinic that is both non-invasive and direct; one promising
technique is near-infrared spectroscopy (NIRS). Because of its low absorption in tissue,
electromagnetic radiation within the near-infrared wavelength spectrum (700-1000 nm)
can travel farther than visible light. Consequently, this wavelength range is often referred
to as an “optical window” (Jöbsis, 1977). The interaction of electromagnetic radiation
with tissue is governed by two fundamental interactions: absorption and scattering, which
are described in the following sections.
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1.3.1

Electromagnetic Radiation

Electromagnetic radiation can be classified as either ionizing or non-ionizing depending
on how energy is transferred to the surrounding medium. The former carries sufficient
energy per quantum to liberate an electron from an atom or molecule, e.g. x-rays. Nearinfrared light is classified as the latter since it does not have sufficient energy to liberate
an electron. Instead, energy is transferred non-destructively to an absorbing molecule in
tissue by excitation of a vibrational state through a quantum event (i.e. all or nothing). If
the frequency of a photon equals the energy required for a molecule to transition to an
excited state, then the photon is absorbed, otherwise, a photon is re-emitted (i.e.
scattered).
The interactions incurred by a photon as it propagates through a medium is
characterized by the scattering (µs) and absorption (µa) coefficients, which represent the
reciprocal of typical distances traveled before a photon is either scattered or absorbed.
These interactions may alter one or more of a photon’s characteristics: energy, phase,
polarization, and direction, as described in the following sections.

1.3.2

Photon Absorption

In the 1700s, the mathematician Pierre Bouguer was the first to arithmetically describe
light absorption in a non-scattering medium. He discovered that the intensity of
transmitted light (I) is related exponentially to µa and the distance between source and
detector (ρ) in a homogeneous medium:
I=I e

(1.3.1)

where I0 represents the source light intensity. In 1852, August Beer observed that light
absorption was proportional to the concentration (ci) of a light-absorbing molecule in the
medium, which is referred to as chromophore. In the presence of multiple chromophores,
the absorption coefficient can be written as:
μ λ = ln 10 ∑ ε λ c

(1.3.2)
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where ε is the wavelength-dependent extinction coefficient of chromophore i. In tissue,
the main absorbing chromophores of near-infrared (NIR) light are oxyhemoglobin,
deoxyhemoglobin, water, and lipid. The wavelength-dependency of absorption
characteristics are illustrated in Figure 1-3.

Figure 1-3: Absorption coefficients of the main chromophores in tissue plotted as a
function of wavelength; data adapted from Oregon Medical Laser Clinic 2013
Figure 1-3 highlights that the dominant tissue chromophore in the NIR region is
hemoglobin. It is important to realize that light absorption in the optical window is
relatively weak compared to shorter wavelengths, due to the much greater absorption of
hemoglobin, and longer wavelengths due to the increased absorption of water. In
principle, the concentration of the main chromophores can be determined by applying
Equation 1.3.2 to measured absorption coefficients obtained at different wavelengths.
However, the challenge to applying this approach to tissue is the much larger effect of
light scattering.

1.3.3

Photon Scattering

Light scattering may be thought of as a direction-altering event experienced by photons.
Mie theory models scattering events by assuming that photons interact with particles that
can be represented as homogeneous spheres with a refractive index different from the
surrounding medium (Hergert & Wriedt, 2012). The result of the interaction is an elastic
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scattering event, meaning the kinetic energy of the redirected photon remains the same
before and after the interaction.
Photons emitted into a media are directionally oriented, meaning they most likely
travel in the forward direction following a scattering event since there is a higher
probability for small-angle scattering events to occur due to the orientation of the
scattering cross-section. However, forward directionality diminishes with each
consecutive scattering event because with each interaction the probability of the
scattering angle becomes more homogeneous. In a highly scattering medium, the photon
direction quickly becomes isotropic or diffuse (i.e. the direction is random). The average
distance traveled by a photon before its path becomes random is given by the inverse of
the reduced scattering coefficient (µ́s):
μ ≡ 1−g ∙μ

(1.3.3)

where g is the anisotropy factor defined as the average cosine of the scattering angle. It is
a measure of the directionality of elastic scattering (i.e. scattering efficiency) and varies
between 0 and 1.
Tissue is a highly scattering medium due to the many scattering particles (~108),
such as cell membranes, nuclei and organelles, and changes in refractive indices within a
small volume (1 mm3). Therefore, the number of photon scattering events greatly
outnumbers absorption interactions (µ́s >> µa). The main three scattering constituents of a
NIR photon, listed in order of scattering frequency, are lipoprotein membranes,
mitochondria, red blood cells (RBCs), and other cellular components (Cope, 1991).
These tissue scattering particles can be categorized into two types: static and dynamic;
the difference is the variation in phase of the interacting photon over time. Although
scattering events occur more often with static tissue constituents, such as lipoprotein
membranes and mitochondria, the phase change is time invariant, and the major
contribution to the temporal phase fluctuations of a NIR photon is due to moving RBCs
(Bonner & Nossal, 1981; Durduran, Choe, Baker, & Yodh, 2010; Ninck, Untenberger, &
Gisler, 2010). The variation in phase due to motion is an important phenomenon that can
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be exploited to measure flow using NIR light and is explained in Section 1.5, but first, the
mathematical description of light propagation in tissue will be outlined.

1.3.4

Light Propagation in Tissue

Maxwell’s equations describe the propagation of electromagnetic radiation in media. In
tissue, as the electromagnetic radiation travels long distances many scattering events
occur making solutions to Maxwell’s equations intractable. Simplifications and
assumptions are required to solve light propagation in a highly scattering media. In this
section, a brief theoretical derivation of photon diffusion in tissue is presented,
highlighting important relationships.

1.3.4.1

Radiative Transfer Equation

Maxwell’s equations can be approximated by describing light propagation as a stream of
photons. In particular, the complexities of light travel in tissue can be simplified by
characterizing individual photon pathlengths with radiative transport theory (Ishimaru,
1989; Profio, 1989). Radiance is defined as the power of light emitted in a direction per
unit solid angle [W/cm2/sr]. As radiance travels within tissue, the radiative transport
equation (RTE) mathematically models energy conservation by describing the
interactions between particles and radiation:
L r, t, Ω + s ∇ L r, t, Ω + μ + μ L r, t, Ω = μ

L r, t, Ω P Ω, Ω′ dΩ′ + S r, t, Ω

(1.3.4)

where L(r,t,Ω) is the radiance in a medium at position r, traveling in direction Ω, at time
t. The scattering phase function, P(Ω,Ω՜ ), represents the probability of scattering into a
direction Ω՜ from direction Ω. The speed of light in the medium is v, the source term is
S(r,t,Ω), and dΩ՜ is the solid angle around Ω.
In an infinitesimal volume, Equation 1.3.4 accounts for energy gains due to the
light source and photon scattering into the volume. Also, Equation 1.3.4 accounts for
energy losses due to absorption and scattering out of the volume. Although the RTE
simplifies Maxwell’s equations, it remains complex with no analytical solution. Further
approximations are required to solve the RTE.
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1.3.4.2

Diffusion Approximation

The diffusion approximation (DA) is the most common solution applied to radiative
transfer theory for light propagation in tissue, which is assumed to be a highly diffusive
process. Within the DA, a standard method, known as the P1 approximation, expands all
angular dependent quantities (i.e. radiance, phase function, and light source) in a
spherical Legendre series truncated at the first moment. To simplify the RTE, the P1
approximation assumes the following:
•

A highly scattering medium (i.e. µ́s >> µa).

•

The scattering phase function, P(Ω,Ω՜ ), is isotropic.

•

For the normalized phase function, the scattering amplitude depends on the change
in direction of the photon only.

•

The source-detector separation is much larger than the typical distance traveled by a
photon before its direction becomes isotropic (i.e. ρ >> µ́s).

•

Slow temporal variations in photon flux (i.e. changes in photon flux occur quicker
than a photon traveling in a single transport length).

•

Light is unpolarized.

Linearly combining the total power of photons incident on a sphere of cross-sectional
area [W/cm2], the photon fluence rate, Φ(r,t), is given by:
Φ r, t ≡

L r, t, Ω dΩ

(1.3.5)

and the vector sum of the radiance emerging from an infinitesimal volume [W/cm2]
defined as the photon flux, J(r,t):
J r, t ≡

Ω ∙ L r, t, Ω dΩ

(1.3.6)

Derived in detail elsewhere (L. V. Wang & Wu, 2009), the P1 approximation gives
radiance independent of direction as:
L r, t, Ω =

Φ r, t +

J r, t Ω

(1.3.7)
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Inserting Equation 1.3.5 into the RTE (Equation 1.3.4) and integrating over all solid
angles, a relationship that is known as the continuity equation for the fluence rate is
obtained:
Φ r, t + ∇ J r, t + μ r, t Φ r, t = S r, t

(1.3.8)

Fick’s law describes the diffusion of photons in a scattering medium and provides the
relationship between fluence rate and flux of a photon by:
J r, t = −

,

∇ Φ r, t

(1.3.9)

Where the photon diffusion coefficient is defined as:
D r, t ≡

(1.3.10)

To describe the radiance of the RTE (Equation 1.3.4) by the photon fluence rate alone,
Fick’s law (Equation 1.3.9) is substituted into Equation 1.3.8 to obtain the photon
diffusion equation (PDE).

1.3.4.3

Photon Diffusion Equation

In a low absorbing, high scattering medium, such as tissue, the photon fluence rate,
Φ(r,t), can be described by the PDE:
D r, t ∇ − μ r, t −

Φ r, t = − S r, t

(1.3.11)

In tissue, the path taken by many individual photons that scatter isotropically and travel
with a constant velocity between scattering events can be characterized by Equation
1.3.11.

1.4 Quantitative Near-Infrared Spectroscopy Techniques
Accurate modeling of photon propagation through tissue has enabled the development of
various NIRS methods for quantifying physiological parameters, such as blood flow and
tissue oxygenation, by use of the DA to estimate the absorption and scattering
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coefficients (Boas & Yodh, 1997; Maret & Wolf, 1987; D. J. Pine, Weitz, Chaikin, &
Herbolzheimer, 1988; A. Yodh & Chance, 1995). One method of categorizing the
different NIRS methods is by the type of light source used, which leads to different
analytical solutions to the PDE.

1.4.1

Near-Infrared Techniques

Near-infrared spectroscopy techniques typically couple the output of a light source to an
optical fiber placed on the surface of a medium in order to deliver photons into the
medium. A second optical fiber (or fiber bundle) placed on the same medium will collect
photons that have escaped, either by reflection or transmission. These detected photons
carry information about the interactions experienced with scattering particles as they
travel through the medium. For a thick medium, such as the human head, collecting
transmitted photons is not feasible due to light absorption and, therefore, reflection
methods are used commonly. Utilizing this general approach, various NIR methods have
been developed that are described below.

1.4.1.1

Continuous-Wave NIRS

Continuous-wave (CW), which is the simplest NIR method, uses a steady-state light
source. The change in reflected light intensity measured a few centimeters from the
source can be characterized by a modified Beer-Lambert Law or the steady-state solution
to the PDE (Delpy et al., 1988; Wray, Cope, Delpy, Wyatt, & Reynolds, 1988). CW light
sources can be either broadband (i.e. emits over a wide spectral range) or at multiple
discrete wavelengths using light emitting diodes (LEDs). Although the equipment is
inexpensive, measuring only light intensity at a few wavelengths does not provide
sufficient information to separate the effects of absorption and scatter (Siegel, Marota, &
Boas, 1999). Consequently, most CW NIRS methods are limited to measuring relative
changes in the concentrations of chromophores. Estimations of the photon path length
can be derived separately from Monte Carlo simulations or physical models (Delpy et al.,
1988), but quantification typically relies on more complex NIRS approaches to directly
measure the effects of scattering (Matcher & Cooper, 1994; Matcher, Cope, & Delpy,
1993; Nicklin, Hassan, Wickramasinghe, & Spencer, 2003).
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1.4.1.2

Frequency-Domain NIRS

This technique modulates the source intensity at a known frequency and uses detectors
capable of detecting the amplitude and phase change of the modulated light (Fantini et
al., 1995). Since the phase shift is linearly related to the mean photon pathlength
(Arridge, Cope, & Delpy, 1992; Patterson, Chance, & Wilson, 1989), FD NIRS provides
a means of quantifying both µa and µ́s. Knowledge of phase enables direct conversion of
the detected changes in light attenuation into changes in chromophore concentration. The
optical properties can be determined by applying a solution to PDE to the measured phase
shift and modulation amplitude in the frequency domain (Delpy et al., 1988; Madsen et
al., 1994). Although quantitative information is provided by FD NIRS, it is more
technically complex than CW NIRS, requiring a frequency generator to modulate the
emission light and a detector that detects both the changes in phase and amplitude of the
reflected light.

1.4.1.3

Time-Resolved NIRS

Similar to FD NIRS, another method capable of determining the tissue optical properties
is time-resolved (TR) NIRS. With this approach, pulsed light is emitted into a medium
and the arrival times of photons, which vary depending on their pathlength, are measured
(Delpy et al., 1988; Montcel, Chabrier, & Poulet, 2005; Patterson et al., 1989). Millions
of detected photons are binned based on their arrival time to generate a histogram (Figure
1-4), which is referred to as the temporal point spread function (TPSF). The dispersion of
the time-of-flight of the detected photons is due to the difference of paths through the
medium caused by photon scattering; however, some of the broadening of the TPSF is
also a result of temporal dispersion within the instrumentation. Therefore, deconvolution
of the measured TPSF and the measured instrument response function (IRF) isolates the
true distribution of time-of-flights (DTOF) of the photons in the medium alone (Diop &
St. Lawrence, 2012). The tissue optical properties can be determined using an analytical
solution to the PDE (Equation 1.3.11) to characterize the DTOF (Patterson et al., 1989).
Since late arriving photons have the highest probability of traveling deeper into the
medium, TR NIRS provides improved depth sensitivity (Diop & St. Lawrence, 2013;

17

Kienle, Glanzmann, Wagnières, & Bergh, 1998; Selb, Stott, Franceschini, Sorensen, &
Boas, 2005).

Figure 1-4: Measured dispersion of photon arrival times due light interrogating the
optical instrument components and medium (TPSF)

1.4.2

Measuring Tissue Oxygen Saturation by NIRS

As discussed above, the optical properties of tissue can be determined by the combination
of different NIRS methods and the PDE (Delpy & Cope, 1997). Since absorption depends
on wavelength (Equation 1.3.2), the concentration of deoxy- and oxy- hemoglobin (i.e.
[Hb] and [HbO2], respectively) can be determined by measuring light absorption at two
or more wavelengths (Figure 1-3). NIRS provides a means for assessing oxygen
metabolism, which is the dominant source of tissue energy. The balance between oxygen
supply and metabolic energy demands is reflected by tissue oxygen saturation (StO2) and
is related to hemoglobin concentrations by the definition:
StO ≡

(1.4.1)

where StO2 represents the local average blood oxygenation of tissue and is related to the
tissue constituents of arterial (SaO2) and venous (SvO2) hemoglobin by:
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StO = a ∙ SaO + b ∙ SvO

(1.4.2)

where a and b are fractional constants of the arterial and venous saturation in tissue that
sum to 1 (Watzman et al., 2000).
Reductions in StO2 have been shown previously in muscle during occlusion of the
forearm and during muscle contractions (De Blasi, Fantini, Franceschini, Ferrari, &
Gratton, 1995; Ferrari, Binzoni, & Quaresima, 1997). Also, in the neonatal ICU, expected
reductions in StO2 during apnoea were detected (Brazy, Lewis, Mitnick, & Jobsis, 1985),
and asphyxiated newborns that show an increase in cerebral StO2, relative to healthy
controls, correlate with abnormal outcome (Zaramella et al., 2007). Tissue oxygen
saturation is an indicator of metabolism in muscle and brain; however, this measurement
may be confounded by the delivery of oxygen by blood flow (Boas & Franceschini,
2011). Therefore, oxygen consumption is better assessed by measuring both StO2 and
blood flow.

1.4.3

Measuring Tissue Perfusion by Dynamic Contrast-Enhanced
NIRS

NIRS can quantify tissue perfusion by utilizing oxy-hemoglobin as an endogenous flow
tracer (Edwards et al., 1988; Elwell et al., 1994) or with the aid of an exogenous contrast
agent (Diop et al., 2010; Elliott et al., 2014). The latter provides superior signal-to-noise
(SNR) since the absorption change related to perfusion is much greater. Perfusion is
quantified by dynamic contrast-enhanced (DCE) NIRS using a tracer kinetic model to
relate the concentration of dye in the tissue to the amount being delivered by arterial
blood (Brown et al., 2002; Elliott, Diop, Tichauer, Lee, & St. Lawrence, 2010; St.
Lawrence et al., 2013):
C t = CBF ∙

C t − u ∙ R u du

(1.4.3)

where Ct(t) is the dye concentration in tissue as a function of time (t) measured by NIRS,
and Ca(t) is the arterial blood concentration measured by a dye oximeter (Brown et al.,
2002). R(t) is defined as the impulse residue function and it represents the fraction of
tracer in the tissue at time t following an idealized bolus injection at t = 0 (i.e. the injected
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tracer can be represented by a delta function with unit area). The flow-scaled impulse
residue function, CBF·R(t), can be extracted by deconvolution, and its initial height
equals CBF since by definition R(0) ≡ 1. This method can be used to quantify cerebral
perfusion, but it does not provide a means for monitoring CBF since each measurement
requires an injection of the contrast agent (Diop et al., 2010).

1.4.4

Cerebral Metabolic Rate of Oxygen

The ability of NIRS to quantify both cerebral oxygenation and CBF makes it possible to
assess the CMRO2 (Elwell et al., 2005), which is considered a better indicator of tissue
viability than CBF alone (Powers et al., 1985). The CMRO2 is related to CBF by the Fick
principle (i.e. conservation of mass):
CMRO = CBF ∙ O

− O

(1.4.4)

where [O2]a and [O2]v are the oxygen concentration in the incoming arteries and outgoing
veins, respectively. The former can be determined by pulse oximetry while the latter can
be estimated from StO2 (Section 1.4.2). Quantification of CMRO2 can be obtained by
combining StO2 with absolute CBF measurements from DCE NIRS (Section 1.4.3)
(Tichauer, Brown, Hadway, Lee, & St. Lawrence, 2006; Tichauer, Hadway, Lee, & St.
Lawrence, 2006; Tichauer et al., 2010). However, real-time CMRO2 monitoring requires
a perfusion technique capable of measuring CBF continuously.

1.5 Diffuse Correlation Spectroscopy
The recent emergence of an optical technique, known as DCS, provides a means of
monitoring CBF that does not require the injection of an exogenous contrast agent (Boas,
Campbell, & Yodh, 1995; Buckley, Parthasarathy, Grant, Yodh, & Franceschini, 2014).
DCS is a variation of another technique, known as dynamic light scattering, which was
developed in the 1960s to analyze speckle intensity fluctuations (Cummins & Swinney,
1970; Pecora, 1972). The theory was investigated in dilute “single-scattering”
experiments to characterize the size of particles (Berne & Pecora, 1976; Riva, Ross, &
Benedek, 1972; Stern, 1975). Shortly after, “single-scattering” experiments evolved into
“multiple-scattering” experiments in soft condensed matter by diffusing-wave
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spectroscopy (DWS) (Bonner & Nossal, 1981; D. Pine, Weitz, Chaikin, &
Herbolzheimer, 1988). Since DCS is an optical technique that uses NIR light, it has the
same promising principles as NIRS (i.e. safe, non-invasive, fast temporal resolution,
probes deep tissue, and is portable). However, it also provides the ability to monitor the
motion of scatterers, which is dominated by the movement of RBCs in tissue. This
following section provides the theory of DCS to measure blood flow changes.

1.5.1

Measuring the Intensity Autocorrelation Function

As described in Section 1.3, NIR photons propagating into tissue encounter many
scattering interactions, including from dynamic erythrocytes (Figure 1-5A). At the
location of a detector on the surface of the interrogated medium, the light electric fields
constructively/destructively interfere to produce a speckle intensity (i.e. bright and dark
spots). Due to the motion of RBCs, the phase of interacting photons is altered, which in
turn, modulate the interference at the detector, causing transient intensity fluctuations
(Figure 1-5B). Faster moving RBCs cause the speckle intensity fluctuations to occur
more rapidly, inducing earlier decreases in the temporal coherence, which is a measure of
the degree of phase correlation (Figure 1-5C).

Figure 1-5: Illustration of diffuse correlation spectroscopy; adapted from (Wesley B
Baker et al., 2014; Zhou, 2007)
(A) Single photons are emitted into a homogeneous tissue where they propagate and experience multiple
scattering events predominantly from moving RBCs. The solid and dotted lines represent the pathlengths of
two photons measured at time t and at a later time delayed by (i.e. t + ), respectively. (B) At the detection
site, temporal intensity fluctuations are measured. (C) Normalized intensity autocorrelation function is
computed by a correlator board; red and blue decay curves represent fast and slow blood flow, respectively.

To assess tissue perfusion, a normalized intensity autocorrelation function is
computed from the measured speckle light intensity fluctuations:
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g ρ, τ ≡
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〈

,
, 〉

〉

(1.5.1)

where, τ is the correlation time and <I(ρ,t)> is the light intensity detected at the tissue
surface at a distance ρ from the source at time t. Equation 1.5.1 is related to the
normalized electric field autocorrelation function, g1(ρ,τ), by the Siegert relationship
(Lemieux & Durian, 1999):
g ρ, τ = 1 + β|g ρ, τ |

(1.5.2)

where β is the coherence factor of the detection system.
For a high scattering, low-absorbing medium, the electric field autocorrelation
function, g1(ρ,τ), satisfies the PDE (Section 1.3.4.3) for a continuous light source (Boas et
al., 1995; Cheung, Culver, Takahashi, Greenberg, & Yodh, 2001):
g ρ, τ = 〈

,

, 〉
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(1.5.3)

where the unnormalized electric field autocorrelation function, G1(ρ,τ), can be modeled
by the correlation diffusion equation (CDE) (Boas et al., 1995; Skipetrov & Maynard,
1996).

1.5.2

Correlation Diffusion Equation

In 1990’s, an equivalency between correlation transport and photon transport was
introduced, which treats the transport of correlation through turbid medium similar to
radiative transport theory (Ackerson, Dougherty, Reguigui, & Nobbmann, 1992). The
difference between radiative and correlation transport is that the former maintains energy
conservation whereas the latter accumulates correlation decay from each scattering event
with dynamic particles resulting in a loss of coherence. This difference is described
theoretically by scattering. Radiative transport assumes energy is conserved as a photon
scatters in and out of an infinitesimal volume, whereas correlation transport similarly
describes a transfer of correlation, except that a photon scattering into the infinitesimal
volume has accumulated a loss of coherence (i.e. correlation decay). By mathematically
applying this difference between radiative and correlation transport theory to Equation
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1.3.4, similarly for a high scattering, low-absorbing medium, the PDE (Equation 1.3.11)
can be modeled by the CDE (Boas et al., 1995; Skipetrov & Maynard, 1996):
D r, t ∇ − μ r, t − μ τ G r, τ = − S r, τ

(1.5.4)

where µD accounts for the loss of correlation due to dynamical processes (i.e. the motion
of scatterers) and is given by:
μ τ =

μ + αµ′ k 〈r τ 〉

(1.5.5)

where, k0 = 2πn/λ is the wavenumber of light (λ is wavelength and n is the refractive
index), α is the proportion of moving scatters, which is predominantly RBCs in tissue
(Bonner & Nossal, 1981; Ninck et al., 2010), to all scatterers and is related to the blood
volume, and <∆r2(τ)> is the mean-square displacement of the moving scatterers during a
correlation time τ.
To relate g2(ρ,τ) to blood flow, the CDE is solved by an appropriate analytical
model that characterizes the motion of RBCs and the interrogated geometry. This can be
challenging as the motion of RBCs is not well understood and the geometry, such as the
adult head, can be complex due to tissue heterogeneities.
In tissue, the loss of coherence is predominately affected by the movement of
erythrocytes in the microvasculature (Ninck et al., 2010). Originally, a photon is thought
to have sequentially scattered off of moving RBCs within different vessels due to the
torturous nature of microvasculature. Therefore, the direction of moving RBCs relative to
the multiply-scattered photon is assumed to be random (i.e. <∆r2(τ)> = V2τ2, where V is
the velocity of the moving scatterers). However, autocorrelation functions are best fit by
assuming the motion of dynamic scatterers as Brownian diffusion (i.e. <∆r2(τ)> = 6DBτ,
where DB is the effective diffusion coefficient). The loss of coherence of the photon may
be best explained by within-vessel scattering due to tissue shearing, tumbling, and rolling
experienced by an erythrocyte as it moves within a vessel; however, characterizing the
motion of dynamic scatterers requires further investigation. The Brownian diffusion flow
model has been successfully applied to a wide range of tissue types to fit for the αDB term
(Durduran, Choe, et al., 2010), which is commonly refferred to as a blood flow index
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(BFI) in tissue. Most applications of DCS, such as the head of neonatal infants, assume a
semi-infinite homogeneous medium, which is acceptable if the thickness of the
extracerebral layers is relatively thin (Buckley et al., 2014; Durduran & Yodh, 2014).

1.5.3

Analytical Solution for a Homogeneous Medium

Currently, the most common analytical solution applied to analyze DCS data assumes
light propagates in a semi-infinite (i.e. no light transmission) homogeneous medium. The
solution for G1(ρ,τ) is given by:
G ρ, τ =

−

(1.5.6)

where, r1 = [ρ2 + z02]½ and r2 = [ρ2 + (z0 + 2zb)2]½. z0 is the effective depth of the source
and is defined as 1/µ́s, zb is the extrapolated boundary and is defined as
2D(1+Reff)(1-Reff)-1 (Kienle & Glanzmann, 1999). D is the diffusion coefficient (Equation
1.3.7) and Reff is the effective reflection coefficient given by 0.493 for the refraction
indices of tissue and air (Haskell et al., 1994). This solution has been verified against
many flow modalities to demonstrate quantitative flow changes in various tissues
(Buckley et al., 2014; Mesquita et al., 2011). When applied to adults, cerebral perfusion
can be underestimated due to partial volume errors from thick extracerebral layers
(Durduran et al., 2004; Gagnon, Selb, & Boas, 2008).
A few approaches have emerged to account for tissue heterogeneity in the adult
head including the application of a correction factor based on partial volume estimates
(Durduran et al., 2004). Another approach is to weight the fit of the semi-infinite
homogeneous model towards shorter correlation times since these are most sensitive to
longer photon pathlengths (i.e. photons that have most likely propagated in deep tissue)
(Selb et al., 2014). However, these methods only enhance sensitivity to CBF from the
measured DCS signal and do not completely separate the effects of light propagation in
the various tissues.
An analytical solution to the CDE (Equation 1.5.4) that separates flow in multiple
tissue layers by accounting for extracerebral tissue thickness have been shown to improve
the sensitivity to CBF (Gagnon, Desjardins, Jehanne-Lacasse, Bherer, & Lesage, 2008),
and to detect CBF increases in the motor cortex during a functional task (Jun Li et al.,
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2005). To-date, only a few studies have employed a multi-layer model, and there have
been no validations of this approach (Jaillon, Li, Dietsche, Elbert, & Gisler, 2007; J Li et
al., 2008; Jun Li et al., 2005).

1.5.4

DCS Instrumentation

To measure g2(ρ,τ), some of the main components include: a continuous-wave, longcoherent (>5 m) light source, a single-mode detection fiber, and a fast counting board and
fast detection system (i.e. avalanche photodiode capable of detecting single photons on
the order of µs). Regarding the source, a long coherence length (typically >5 m) is
required to ensure the light emitted by the source are spatially in-phase for distances
much greater than typical photon pathlengths through tissue (<1 m; estimated from
Figure 1-4). Therefore, the decay of correlation is a result from multiple scattering
interactions with RBCs in tissue and not due to the laser. A single-mode detection fiber
has a very small core radius (~2 µm) comparable to the wavelength of light, which
enables selection of a single scattered electric field component (i.e. receiver mode) to
maximize speckle contrast. However, the small core diameter and low numerical aperture
limit SNR, making it difficult to acquire DCS data at larger source-detector distances (>3
cm), which is often used to improve depth sensitivity. Strategic use of a few-mode
detection fiber can enhance SNR by increasing the photon count rate, but sacrifices
speckle contrast (Dietsche et al., 2007; Gisler et al., 1995; He, Lin, Shang, Shelton, & Yu,
2013).
A fast detection system, such as a single-photon avalanche photodiode (SPAD),
and a fast counting board are required for high temporal resolution and high SNR.
Temporal resolution may be traded in to enhance SNR, but this is not ideal for real-time
monitoring of tissue blood flow. A multi-tau correlator board bins the photons from a
time range scale of µs to seconds and computes the autocorrelation function. Recent
innovative techniques that efficiently select only relevant correlation times have shown to
improve the speed of data acquisition and reduce noise (Baker et al., 2014; D. Wang et
al., 2016). Ultimately, this may enhance the depth sensitivity of DCS techniques since
long photon pathlengths are most likely to travel deep in the tissue and are best
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representative of the autocorrelation function at early correlation times (Selb et al., 2014),
which are most susceptible to noise.

1.6 A Review of Current Applications and Limitations of
DCS
Over the past 10 years, the applications of DCS have grown rapidly due to its clinical
promise (i.e. safe, non-invasive, inexpensive, good depth sensitivity, real-time data
acquisitions, portability) as a bedside monitor of cerebral perfusion. The clinical
applications have been supplemented by a plethora of validation studies, which have been
summarized in a number of recent review articles (Buckley et al., 2014; Durduran, Choe,
et al., 2010; Durduran & Yodh, 2014; Mesquita et al., 2011; Yodh, 2009).
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Table 1-1: A list of DCS validation studies; modified from (Mesquita et al., 2011)
Sample
Mouse
tumour
Rat
Mouse
tumour
Mouse
tumour
Human calf
muscle

Perturbation
PDT
Hypocapnia
PDT

Comparison
Modality
Power Doppler
ultrasound
Laser Doppler
Doppler
ultrasound

R2

Slope

Reference

N/A

0.97

(Menon et al., 2003)

0.94

1.3

N/A

Agreement

(Durduran, 2004)
(Yu, Durduran, Zhou, et
al., 2005)

Antivascular therapy

DCE ultrasound

N/A

Agreement

(Sunar et al., 2007)

Cuff
inflation/deflation

ASL MRI

>0.77

1.5-1.7

(Yu et al., 2007)

TBI

Fluorescent
microspheres

0.63

0.4

(Zhou et al., 2009)

Absolute baseline

TCD

0.91

0.9

Absolute baseline

TCD

0.53

N/A

Hypercapnia

ASL MRI

0.7

0.85

Mouse

Femoral artery
occlusion

Laser Doppler

>0.8

0.96-1.07

(Mesquita et al., 2010)

Rat

Hypercapnia

ASL MRI

~0.84

0.75

(Carp, Dai, Boas,
Franceschini, & Kim,
2010)

Adult
human

Pressors and
hyperventilation

Xenon CT

0.73

1.1

(Kim et al., 2010)

Adult
human

Acetazolamide

TCD

N/A

Agreement

Piglet

Hypo-/hyper-capnia

DCE NIRS

0.93

1.05

Hypercapnia

PC MRI

0.77

0.91

(Buckley et al., 2012)

Hypercapnia

PC MRI

0.59

0.99

(Buckley et al., 2012)

Absolute
Hypercapnia

PC MRI

0.67

0.40

(Jain et al., 2014)

Hypercapnia

PC MRI

0.62

1.01

(Jain et al., 2014)

Indomethacin
Infusion

DCE NIRS

0.68

0.43

(Diop, Kishimoto,
Toronov, Lee, &
Lawrence, 2015)

Piglet
Premature
neonates
Premature
neonates
Term
neonates

Children
(JV)
Children
(SVC)
Neonates
CHD
Neonates
CHD
Neonates
PDA

(Buckley, Cook,
Durduran, & Kim, 2009)
(Roche-Labarbe et al.,
2010)
(Durduran, Zhou, et al.,
2010)

(Zirak, Delgado-Mederos,
Martí-Fàbregas, &
Durduran, 2010)
(Diop, Verdecchia, Lee, &
St Lawrence, 2011)

A list of the abbreviations in Table 1-1: A list of DCS validation studies; modified from (Mesquita et al.,
2011): Dynamic contrast enhanced (DCE) NIRS; Arterial spin labeling (ASL) MRI; Phase-contrast (PC) MRI;
Photodynamic therapy (PDT); Transcranial Doppler ultrasound (TCD); Congenital heart defect (CHD);
Patent ductus arteriosus (PDA); Superior vena cava (SVC); Jugular vein (JV).
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Overall, the majority of validation studies listed in Table 1-1 have concluded that
DCS can accurately track relative changes in blood flow in various tissues. Generally,
DCS is used to measure relative flow since quantification requires accurate estimation of
the tissue optical properties (Diop et al., 2011; Irwin et al., 2011; Z. Li et al., 2015).
However, some validation studies (included in Table 1-1) have correlated BFIs measured
by DCS with perfusion (i.e. transcranial Doppler ultrasound, ASL-MRI, DCE NIRS, and
phase-contrast MRI) suggesting that the BFIs measured by DCS represent true perfusion,
despite its diffusion units [cm2/s] (Buckley et al., 2009; Diop et al., 2011; Jain et al.,
2014; Roche-Labarbe et al., 2010; Yu et al., 2007). The conversion of a BFI obtained by
DCS into perfusion units (mL/100g/min) can be achieved by calibrating DCS from an
independent perfusion measurement, such as by DCE NIRS (Section 1.4.3) (Diop et al.,
2011; Gurley, Shang, & Yu, 2012; Z. Li et al., 2015). This combination of DCS and TR
NIRS also provides a means of quantifying CMRO2 by combining StO2 (Section 1.4.2)
and CBF measurements.

1.6.1

Applications of DCS in Various Tissue Types

Tissue hemodynamics are important for providing sufficient oxygen to meet metabolic
demands. In particular, highly vascularized tissues, such as brain and tumour, are
attractive applications to monitor changes in blood flow by DCS.
Monitoring hemodynamics of skeletal muscle is another growing clinical
application of DCS, particularly for peripheral artery disease. Following calf muscle
ischemia, which was induced by ligating a femoral artery in mice, reperfusion was
established by DCS in 90 % of healthy mice (Mesquita et al., 2010). Another study
acquired optical data in healthy human arm and leg flexor muscles during arterial cuff
occlusion detecting rapid drops in blood flow, but only gradual decreases of oxygen
saturation were found (Yu, Durduran, Lech, et al., 2005). Recently, the BFI measured by
DCS at baseline has been calibrated by a venous-occlusion technique, in which, the
increase rate of blood volume following the release of an occluding artery is converted to
perfusion units by assuming an average hemoglobin concentration and accounting for
hemoglobin molecular weight (Gurley et al., 2012). Later this calibration technique was
further investigated to confirm the total hemoglabin increase rate due to venous-occlusion
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agrees well with BFIs measured by DCS (Z. Li et al., 2015). However, exercise protocols
are susceptible to motion artifacts that can distort the DCS signal. Co-registration
techniques are required to separate true blood flow response from motion artifacts
(Gurley et al., 2012; Shang, Symons, Durduran, Yodh, & Yu, 2010).
In oncology, DCS has been used to characterize tumour hemodynamics with the
goals of detecting highly vascularized tumours and assessing the efficacy of therapeutic
treatments in pre-clinical experiments (Becker, Paquette, Keymel, Henderson, & Sunar,
2010; Sunar et al., 2007; Yu, Durduran, Zhou, et al., 2005) and clinical studies (Choe et
al., 2014; Durduran et al., 2005; Sunar et al., 2010; Yu et al., 2006). In 2005, Durduran et
al. observed increased blood flow in patients with breast tumours, likely due to
angiogenesis (Durduran et al., 2005). Since this original study, cancer applications of
DCS have extended to monitoring photodynamic therapy (PDT) of prostate cancer and
basal cell carcinomas (Becker et al., 2010; Yu et al., 2006). In addition, the effects of
chemotherapy on breast cancer, and head and neck tumours have been investigated
(Sunar et al., 2010; Zhou et al., 2007). All studies observed significant flow effects early
(from minutes to the first week) following cancer therapy treatment, highlighting the
potential of DCS as a tool for monitoring cancer hemodynamic responses; however, all
studies had relatively small sample sizes (<8). Recently, a moderate-sized clinical study
(32 patients) measured significantly high flow in malignant breast cancer by a hand-held
DCS probe (Choe et al., 2014). These studies illustrate the potential for DCS to identify
malignant cancer and monitor optically accessible tumours in the clinic.

1.6.2

Applications of DCS in Brain Tissue

The primary application of DCS has been to monitor CBF. Due to the appeal that signal
contamination from extracerebral tissue is minimal and photons predominantly
interrogate cortical tissue, many animal studies have been conducted in rats, mice and
piglets (Buckley et al., 2014; Durduran & Yodh, 2014). Animal models that mimic
neurocritical conditions have been used to demonstrate the capability of DCS to track
real-time flow changes. For example, in the rat brain, relative CBF during cortical
spreading depression observed an initially strong increase followed by a sustained
decrease (Zhou et al., 2006). Shang et al. showed that DCS could detect large reductions
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in CBF (> 75%) during bilateral occlusion of the common carotid arteries in mice, as well
as reperfusion following unclipping (Shang, Chen, Toborek, & Yu, 2011). A recent study
using a TBI mouse model demonstrated that baseline CBF could be used as a biomarker
of cognitive outcome following repetitive concussions (Buckley et al., 2015). DCS has
also been used to detect the sizable CBF reduction that occurs following acute TBI in a
nonimpact inertial rotational swine model (Zhou et al., 2009).
Due to its good temporal resolution (i.e. order of seconds), DCS has been used to
detect the CBF response to functional activation in humans. The first application was by
Durduran et al. who measured the CBF increase in the motor cortex during a simple
finger tapping task (Durduran et al., 2004). This study paved the way for investigations of
functional monitoring of cerebral hemodynamics by DCS. For example, various oral
tasks were investigated to better understand speech impediments, such as stuttering
(Tellis, Mesquita, & Yodh, 2011). While its adaptation to functional activation tasks
illustrated the versatility of DCS, its greatest promise is as a bedside monitor in the ICU.
Clinical studies have investigated patient management techniques, such as
administering medication and head-of-bed (HOB) strategies. First, administrated dose of
NaHCO3, which is a common medication for acidemia in the ICU, was observed to
linearly relate to CBF increases (Buckley et al., 2013). Also, HOB strategies were
investigated in patients with acute ischemic stroke to observe the effects of CBF by
adjusting the angle of recline of the patient (Durduran et al., 2009; Favilla et al., 2014).
Typically, stroke patients resulted in significant increases of CBF by HOB techniques;
however, some patients responded paradoxically, highlighting the importance of
monitoring neurocritical management techniques to individualize patient care.

1.6.3

Hybrid Optical Modality to Measure CMRO2

As mentioned earlier, the combination of DCS and NIRS provides a safe and noninvasive means to assess CMRO2 at the bedside (Boas & Franceschini, 2011; Buckley et
al., 2014; Durduran, Choe, et al., 2010; Durduran & Yodh, 2014). The first study to
combine photon diffusion methods by a hybrid DCS/NIRS technology measured regional
blood flow, hemoglobin concentration and blood oxygen saturation in rat brain (Cheung
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et al., 2001). The appeal for an all-optical hybrid system capable of measuring cerebral
hemodynamics and cerebral oxygen metabolism in tissue has prompted extensive
research. Next, a hybrid optical system was used to monitor CMRO2 changes during
focal cerebral ischemia in rats (Culver et al., 2003), which was adapted to the adult brain
(Durduran et al., 2004).
Over the last few years, interest in the use of an all-optical hybrid modality has
expanded towards studies measuring relative changes of cerebral metabolism in healthy
infants (Buckley et al., 2009; Goff, Buckley, Durduran, Wang, & Licht, 2010; RocheLabarbe et al., 2010). The idea to measure cerebral metabolism with NIRS is not novel
(Franceschini et al., 2007), but computing CMRO2 with the inclusion of DCS reduced
intersubject variability (Roche-Labarbe et al., 2010). This combination has been used to
map developmental changes in the early stages of life, in which the measured average
metabolism increased by 40 % in newborns over their first 6 weeks of life (RocheLabarbe et al., 2010). Roche-Labarbe et al. later reported lower CMRO2 values at lower
gestational ages (Roche-Labarbe et al., 2012). Furthermore, a couple studies observed
increases in CMRO2 in the injured neonatal brain compared to healthy infants, and
suggest CMRO2 is a better biomarker of brain injury than StO2 alone (Grant, RocheLabarbe, & Surova, 2009; Lin et al., 2013). Aside from monitoring brain development, a
number of studies investigated effects of therapeutic treatments in sick infants. For
example, one study found metabolism to be unaltered during hypercapnia in neonates
with congenital heart disease, despite significant increases in CBF and oxyhemoglobin
(Durduran, Zhou, et al., 2010). Recently, another study investigated infants with patent
ductus arteriosus who underwent treatment by indomethacin, a well-known
vasoconstrictor, and found reductions in CBF and StO2, despite no changes in CMRO2,
before and after pharmaceutical ingestion (Diop et al., 2015). Monitoring the
neurovascular coupling of a developing brain by DCS/NIRS provides a means for early
detection of brain injury and monitoring the efficacy of therapeutic treatment.

1.6.4

Limitations

Despite the employment of DCS in a number of applications, both pre-clinical and
clinical, there remain some limitations that prevent the translation of DCS to the ICU.
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These include susceptibility to motion, sensitivity to probe pressure, low SNR, separation
of blood flow in cerebral and extracerebral tissues, and flow quantification.
Intensity fluctuations measured by DCS are caused primarily by photon
interactions with dynamic scatterers in the interrogated medium. However, additional
fluctuations are falsely detected from static scatterers due to the motion of probes, which
increase the variability of the estimated BFI (Belau et al., 2010). A few possible solutions
are suggested, including glueing the fibers with collodion (Yücel, Selb, Boas, Cash, &
Cooper, 2014), time gating with a dynamometer (Shang et al., 2010), and analytical
approaches that filter artifacts due to motion, similarly to functional NIRS techniques
(Cooper et al., 2012). The latter idea is perhaps the most feasible but little work has
focused on reducing errors due to motion. Current data acquisition setups require the
optical probes to be secured strongly to the interrogated medium in order to limit motion
artifacts.
A more prominent source of error than motion is the effects of contact pressure
between the skin and the DCS probes. Typical pressure (i.e. 20-55 mmHg) required to
hold the optical probes in place on the surface of tissue have been shown to influence the
DCS signal in scalp or muscle (Baker et al., 2015; Mesquita et al., 2013). To avoid errors
caused by pressure variations, non-contact optical probes have been developed (Cheung
et al., 2001; T. Li et al., 2013; Yu, Durduran, Zhou, et al., 2005). Although this technique
is an interesting approach, there are limitations, including detection of stray light and loss
of depth sensitivity. Recent advancements in non-contact probes show comparable
performance to contact probes, (Han et al., 2015; He et al., 2015), but further
technological advancements are required before a non-contact probe can be used to assess
hemodynamics in deep tissue, such as cortical tissue in adults. Furthermore, applying a
non-contact emission probe to the head would be highly susceptible to local
inhomogeneities, such as hair, which limit measurements of the prefrontal cortex via the
forehead. Advantageously, a contact probe provides optimal optical coupling through
hair, especially by designs of the light collection tip, such as a funnel-shaped tip, which
displaces hair from the detection field of view (Dietsche et al., 2007).
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An unavoidable complication of optical methods is the limited depth penetration
of NIR light in a highly scattering medium, such as tissue. The highly scattering medium
makes it difficult to achieve excellent SNR at large source-detector distances since less
light reflected from the medium is detected. A simple solution to improving the SNR is to
increase the laser emission power, but to avoid excessive heating of the skin, the output
power of a continuous laser must be below 28.4 mW (Baker, 2015). In addition, less light
is collected in DCS compared to other NIRS techniques, due to the requirement of singlemode detection fibers. Dietsche et al. improved SNR by collecting light from multiple
fibers, but each fiber must be coupled to its own detector, which can become expensive
(Dietsche et al., 2007).
Another approach for improving SNR or depth sensitivity is by developing robust
instrumentation or data analysis techniques. Rather than computing an autocorrelation
curve at multiple delay times, single correlation times may be used to monitor flow
changes, and the early correlation times may be utilized for better depth sensitivity
(Baker et al., 2014). Also, combining DCS analysis with a software correlator, rather than
the conventional hardware correlator, may provide better fitting results and is less
expensive (Dong et al., 2012). Recently, a new software correlator that computes the
autocorrelation function at selected correlation times was shown to provide temporal
resolutions capable of detecting heart-rate fluctuations in CBF (Wang et al., 2016).
The innovative DCS technologies that improve SNR provide a means to
accurately measure flow changes in deep tissue, such as cortical tissue in the adult head.
Extracerebral tissues are known to contaminate the optical signal, which underestimates
the BFI measured by DCS (Durduran et al., 2004; Gagnon, Desjardins, et al., 2008).
Partial volume errors are a complicated problem with NIR techniques due to the poor
spatial resolution. Originally, a simple approach of applying a correction factor based on
partial volume estimates was suggested (Durduran et al., 2004), but extracerebral tissue
thickness differences between subjects vary the sensitivity of brain tissue. Furthermore,
techniques that adjust the weight of the fit to early correlation times increase the
sensitivity to deeper tissue (Selb et al., 2014); however, they do not separate light
propagation in multiple tissue types.
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A method to separate flow indices in different tissue layers (scalp, skull, and
brain) was used to measure functional activation due to finger tapping (Jun Li et al.,
2005), but only a few studies have investigated the feasibility of using layered models to
improve the accuracy of CBF monitoring (Gagnon, Desjardins, et al., 2008; Jaillon et al.,
2007; Jun Li et al., 2005). The importance of separating scalp and brain is critical since
flow in the scalp dominates the DCS signal (Mesquita et al., 2013). A recent algorithm
has been proposed to separate scalp blood flow (SBF) and CBF by modulating the
pressure between the tissue surface and optical probes (Baker et al., 2015); however, this
technique relies on a pressure calibration stage that induces a flow change in the scalp
only. The authors present an intriguing technique that would be strengthened by
validation with independent flow measures. A model to separate flow estimates in the
brain and the scalp without requiring calibration would be ideal.
Another caveat of flow measured by DCS is the inability to assess absolute
perfusion. Currently, DCS can only measure relative changes in blood flow due to the
arbitrary units [cm2/s] of a BFI. Diop et al. proposed an all-optical approach to convert
the DCS flow index into units of absolute perfusion by measuring CBF by DCE NIRS
(Diop et al., 2011). This technique could also be extended to monitor CMRO2, which is
one of the motivations of this thesis.

1.7 Research Objectives
The goal of this doctoral work was to develop a non-invasive optical imaging system
capable of monitoring blood flow and oxygenation in the cerebral microvasculature of
patients at the bedside. Considering the main goal to develop DCS towards the clinic, the
following objectives were addressed:
1. Design and construct an optical imaging system capable of measuring flow and
oxygenation.
2. Quantify CMRO2 by an all-optical method.
3. Investigate the best model to characterize moving scatterers in the brain.
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4. Develop a multi-layered model to improve depth sensitivity.
5. Validate DCS with computed tomography perfusion (CTP).
Each chapter in this dissertation represents an advancement in the field with the ultimate
goal of developing a safe, non-invasive neuromonitoring device for patients in the ICU.

1.8 Thesis Outline
The remainder of the thesis is divided into three chapters that outline published studies
and a final concluding chapter.

1.8.1

Measurements of Absolute Cerebral Metabolic Rate of
Oxygen by a Hybrid Optical Modality that Includes Diffuse
Correlation Spectroscopy (Chapter 2)

An all-optical imaging technique was employed to measure changes in absolute CMRO2
in newborn piglets, which were validated against an invasive gold standard method. This
chapter is based on the paper entitled “Quantifying the cerebral metabolic rate of oxygen
by combining diffuse correlation spectroscopy and time-resolved near-infrared
spectroscopy”, published in the Journal of Biomedical Optics in 2013 by Verdecchia K,
Diop M, Lee T-Y, and St. Lawrence K.

1.8.2

Measurements of Cerebral Blood Flow in Pigs by Diffuse
Correlation Spectroscopy on the Exposed Cortex (Chapter
3)

Motivation for describing motion of RBCs as Brownian diffusion is not well understood
but is applied frequently by DCS studies due to its superior fit than other models. This
chapter investigates the best flow model to characterize blood diffusion in cortical tissue
by placing the optical probes directly on the exposed brain of adolescent pigs in order to
remove any confounding effects of extracerebral tissues. Furthermore, the validity of the
CBF changes measured by DCS was compared to CTP. This chapter is based on the
paper entitled “Assessment of the best flow model to characterize diffuse correlation
spectroscopy data acquired directly on the brain”, published in Biomedical Optics
Express in 2015 by Verdecchia K, Diop M, Morrison LB, Lee T-Y, and St. Lawrence K.
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1.8.3

Measurements of Cerebral Blood Flow in Adolescent Pigs by
Diffuse Correlation Spectroscopy (Chapter 4)

In the adult head, the extracerebral tissues highly dominate an optical signal resulting in
underestimating CBF changes by DCS. A multi-layered model was implemented in
adolescent pigs to separate the blood flow in cerebral and extracerebral tissues.
Furthermore, the validity of the CBF changes measured by a multi-layered DCS
technique was compared to CTP. This chapter is based on the paper entitled “Assessment
of a multi-layered diffuse correlation spectroscopy method to monitor cerebral blood
flow changes in adults”, published in Biomedical Optics Express in 2016 by Verdecchia
K, Diop M, Lee A, Morrison LB, Lee T-Y, and St. Lawrence K.

1.8.4

Conclusion and Future Work (Chapter 5)

In the final chapter, the main results from the thesis are summarized and a discussion is
provided on their experimental and clinical implications. Based on the findings in this
thesis, areas of interest for future work are discussed and principle conclusions are
presented.
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Chapter 2

2

Measurements of Absolute Cerebral Metabolic Rate of
Oxygen by a Hybrid Optical Modality that Includes
Diffuse Correlation Spectroscopy

This chapter is adapted from the paper entitled “Quantifying the cerebral metabolic rate
of oxygen by combining diffuse correlation spectroscopy and time-resolved near-infrared
spectroscopy” by Verdecchia K, Diop M, Lee T-Y, St. Lawrence K, published in the
Journal of Biomedical Optics vol. 18(12) pp. 27007 (2013).

2.1 Introduction
Improvements in neonatal intensive care have reduced the mortality rate associated with
preterm birth, but unfortunately these infants remain at a high risk of neurological
complications, including learning disabilities and cerebral palsy (Behrman, 2006).
Preterm infants are vulnerable to ischemic and hemorrhagic brain injury in part because
of an underdeveloped cerebral vasculature, including limited or impaired autoregulation
(Volpe, 1990). As a result, unstable arterial blood pressure could lead to dangerous
fluctuations in cerebral blood flow (CBF). Recent studies using near-infrared
spectroscopy (NIRS) to monitor cerebral blood oxygenation have reported that periods of
impaired autoregulation are not uncommon in preterm infants; however, a correlation
between the occurrence of impaired autoregulations and brain lesions was not observed
(O’Leary et al., 2009; Soul et al., 2007; Wong et al., 2008).
Using cerebral blood oxygenation to identify critical CBF thresholds is potentially
confounded by the indirect relationship between cerebral blood oxygenation and CBF, as
the former also depends on the cerebral metabolic rate of oxygen (CMRO2), the cerebral
blood volume (CBV) and arterial oxygen saturation (J. Cooper et al., 2011). An
alternative approach would be to combine NIRS with diffuse correlation spectroscopy
(DCS), an emerging optical method sensitive to CBF (Boas & Yodh, 1997; Cheung,
Culver, Takahashi, Greenberg, & Yodh, 2001; Durduran et al., 2010). This combination
has the advantage of providing a means of monitoring both CBF and CMRO2 (Durduran
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et al., 2004; Roche-Labarbe et al., 2010, 2012). The latter can be determined from blood
oxygenation and flow measurements and is considered a more sensitive indicator of
tissue viability (Boas & Franceschini, 2011; Powers, Grubb, Darriet, & Raichle, 1985).
For example, CMRO2 has been shown to be more sensitive to the severity of cerebral
hypoxia-ischemia than NIRS oxygenation measurements alone (Tichauer, Brown,
Hadway, Lee, & St. Lawrence, 2006; Tichauer, Elliott, Hadway, Lee, & St. Lawrence,
2009). The combination of NIRS and DCS could therefore help identify clinically
significant passive-pressure CBF by detecting flow fluctuations large enough to affect
cerebral energy metabolism.
The purpose of this study was to demonstrate that changes in absolute CMRO2
could be measured by combining NIRS and DCS. In order to quantify CMRO2,
techniques for measuring absolute CBF and cerebral blood oxygenation are required. In
this study, relative blood flow changes measured by DCS were converted into units of
CBF using a bolus-tracking time-resolved (TR) NIRS technique to measure baseline CBF
(Diop, Verdecchia, Lee, & St. Lawrence, 2011). Cerebral blood oxygenation was
determined from multi-wavelength TR NIRS measurements. The accuracy of the
oxygenation measurements was assessed by directly measuring blood oxygenation in the
sagittal sinus. The sensitivity of the hybrid approach to changes in CMRO2 was
investigated by manipulating cerebral metabolism in newborn piglets by altering the
anesthetics and by injecting sodium cyanide, a mitochondrial inhibitor (C. Cooper et al.,
1999; Tichauer, Hadway, Lee, & St. Lawrence, 2006).

2.2 Methods
2.2.1

Animal Model

This study was approved by the Animal Use Subcommittee at Western University.
Experiments were carried out on newborn Duroc pigs (<3 days old). All surgical
procedures were performed while piglets inhaled 3-4% isoflurane. Piglets were
tracheotimized and mechanically ventilated on an oxygen/medical air mixture. Catheters
were inserted into an ear vein, the left femoral artery, and superior sagittal sinus through
a burr hole drilled into the skull. The ear catheter was used to inject the light absorbing
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dye, indocyanine green (ICG) (Sigma-Aldrich, Missouri, US), and the different drugs
used in the experiment. The femoral and sagittal sinus catheters were used to acquire
blood samples in order to determine the oxygen saturation of arterial blood (SaO2) and
cerebral venous blood (SvO2), respectively. The superior sagittal sinus primarily drains
the cerebral cortex, which is the brain region interrogated by the optical probes (Scremin,
Sonnenschein, & Rubinstein, 1982). The femoral line was also used to monitor heart rate
(HR), blood pressure, blood gases (paCO2 and paO2), and blood glucose (BG). A 1-2 ml
infusion of a 25% glucose solution was administered intravenously if glucose levels fell
below 4.5 mmol/L. A heated water mattress was used to maintain rectal temperature
between 37.5 and 38.5°C throughout the experiment. After surgery, the optical probes
were positioned on the scalp using a custom-made probe holder with a source-detector
separation of 20 mm. A separation of 10 mm between the probes from the two optical
systems ensured that they interrogated roughly the same brain region. No data were
acquired for at least 30 minutes following surgery to ensure the piglet was
physiologically stabile. Baseline conditions were identified by blood samples revealing
normal paCO2 and paO2: 38-42 mmHg and 100-170 mmHg, respectively (Reivich, 1964).

2.2.2

Experimental Procedure

Five different cerebral metabolic states were induced by manipulating the anesthetics and
by injecting sodium cyanide. Following a change of condition, data acquisition was
delayed by approximately 5 min to allow time for cerebral metabolism to stabilize. Under
each condition, DCS was used to measure the blood flow index (BFI) and multiwavelength TR NIRS was used to measure the oxygen saturation of cerebral tissue
(ScO2) (see instrumentation section). Blood samples (0.3-0.5 ml) were drawn from the
femoral artery and the sagittal sinus to determine SaO2 and SvO2, by hemoximetry
(ABL80 Flex Co-ox, Radiometer, Copenhagen, DK). The DCS and TR NIRS data were
acquired in three blocks during each condition (Figure 2-1). In each block, 96 TR NIRS
measurements were acquired with an integration time of 1 s and 20 DCS measurements
were acquired with an integration time of 30 s. All data sets for each condition were
acquired within approximately 45 minutes.
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Figure 2-1: Diagram of the experimental protocol
An experimental protocol diagram showing the induced metabolic conditions in chronological order with the
sequence of measurements acquired at each condition. The solid boxes are distinctive steps, whereas the
dotted box is recurring for each induced condition numbered I-V.

Initial baseline measurements were acquired under 1.75-2% isoflurane mixed with
a combination of medical air and oxygen to maintain normal paO2. In addition to the
standard data acquisition protocol, CBF was measured by a dynamic contrast-enhanced
TR NIR method using ICG as an intravascular contrast agent (Brown et al., 2002). This
method requires injecting an intravenous bolus of ICG (0.01 mg/kg), followed by
measuring the time-varying concentration of ICG in arterial blood and the brain. The
brain ICG concentration curve was determined by acquiring a series of TR NIR
measurements at a sampling rate of 400 ms. The arterial concentration curve was
measured using a pulse dye densitometer (DDG 2001, Nihon Kohden, Tokyo, JP)
attached to a foot. Three successive sets of ICG data were acquired to improve the
precision of the baseline CBF measurement. Successive ICG injections were separated by
10 min to allow time for ICG clearance from the previous injection. The average value of
CBF was used to convert subsequent DCS BFI measurements into units of CBF (Diop et
al., 2011).
Following the baseline measurements, TR NIRS and DCS were used to measure
ScO2 and the BFI, respectively, under four conditions. First, CMRO2 was increased by
discontinuing isoflurane and starting an intravenous infusion of fentanyl (0.02 mg/kg/h)
combined with inhalation of 70% nitrous oxide (N2O). Second, the barbiturate
pentobarbital (5 mg/kg) was injected intravenously to decrease CMRO2. Cerebral energy
metabolism was further reduced by switching off the fentanyl/N2O mixture, returning the
piglet to isoflurane (1.75-2%), and administering another 5 mg/kg of pentobarbital. For
the final condition, sodium cyanide was injected intravenously at a dose of 5 mg/kg. This
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non-lethal dosage of cyanide is insufficient to completely inhibit mitochondrial function
(Sakamoto et al., 2001); however, it is sufficient to reduce mitochondrial respiration (C.
Cooper et al., 1999).

2.2.3

Instrumentation

2.2.3.1

Time-Resolved NIRS System

The TR instrument for the ScO2 measurements consisted of three picosecond diode lasers
emitting at 760, 802 and 830 nm (LDH-P-C-810, PicoQuant, Berlin, DE). The output and
pulse repetition rate of each laser were set to 1.4 mW and 29.3 MHz, respectively. A
variable neutral density filter (NDC-50-4M, Thorlabs, Newton, New Jersey, US) was
placed in front of each laser to adjust the intensity of the beam before the light was
coupled into a multimode fiber (emission probe: N.A. = 0.22, core = 400 µm, 4.7 mm
outer diameter; Fiberoptics Technology, Pomfret, Connecticut, US). Fibers of different
lengths, forming a bundle, were used to provide time multiplexing (Contini et al., 2006).
For the ICG bolus-tracking measurements, only the 802 nm laser was used at a repetition
rate of 80 MHz to optimize the signal-to-noise ratio (SNR) (Diop, Tichauer, Elliott,
Migueis, & Lee, 2010).
Reflected light from the head was collected with a 1.5 m long multimode fiber
placed 20 mm from the emission fiber bundle on the piglet’s intact head. The collected
photons were then sent to a Peltier-cooled photomultiplier tube (PMT) (PMC-100,
Becker & Hickl, Berlin, DE), coupled to a time-correlated single photon counting module
(SPC-134, Becker & Hickl, Berlin, DE). Temporal point spread functions (TPSFs) were
computed by synchronizing the photon detection with the laser pulse trigger provided by
the driver (PDL 828, PicoQuant, Berlin, DE). Each TPSF was acquired for one second
for the oxygenation measurements and 400 ms for the ICG bolus-tracking method.
Temporal dispersion caused by the system was corrected for by measuring the instrument
response function (IRF) (Diop, Tichauer, Elliott, Migueis, Lee, et al., 2010). To avoid
artifacts such as instrument temporal drift, the TR NIRS system was allowed a 1.5 h
warm up delay period prior to the experiment (Diop, Tichauer, Elliott, Migueis, & Lee,
2010; Ntziachristos & Chance, 2001).
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2.2.3.2

Diffuse Correlation Spectroscopy

The DCS light source was a continuous-wave laser emitting at 785 nm (DL785-100-S,
CrystalLaser, Nevada, US) with a maximum output power of 100 mW and a coherence
length greater than 5 m. Similar to the time-resolved setup, the laser beam was first
attenuated by a variable neutral density filter (NDC-50-4M, Thorlabs, New Jersey, US)
and then coupled into an emission fiber (emission probe: N.A. = 0.22, core = 400 µm, 4.7
mm outer diameter; Fiberoptics Technology, Connecticut, US). Photons scattered from
tissue were detected at a distance of 20 mm away from the emission probe using a 4-m
single-mode fiber (SMF-28e+, N.A. = 0.14, core = 125 µm, single-mode cutoff
wavelength at 1260 nm). Since the detection fiber is a few-mode fiber at the laser
emission wavelength, the fiber was wrapped into a 15 cm coil to attenuate the higherorder modes by converting them into non-propagating modes (Dietsche et al., 2007; Diop
et al., 2011; Gisler et al., 1995). Photons were detected by a single photon counting
module (SPCM-AQR-15-FC, PerkinElmer Canada Inc, Quebec, CA). The output from
the detector was sent to a correlator board (DPC-230, Becker & Hickl, Berlin, DE) to
compute the normalized intensity autocorrelation function.

2.2.4
2.2.4.1

Data Analysis
Measuring Cerebral Oxygen Saturation by TR NIRS

Brain tissue optical properties (i.e. the absorption and reduced scattering coefficients, µa
and µ́s, respectively) were quantified using the solution to the diffusion approximation for
a semi-infinite turbid medium with extended boundary conditions (Kienle & Patterson,
1997). The three sets of TPSFs collected at each condition were averaged together and
were fit by the theoretical model convolved with the measured IRF (Ntziachristos &
Chance, 2001). Initial values for µa, µ́s, and an amplitude scaling factor were obtained by
analyzing the baseline data with a three-parameter non-linear fitting routine (Diop,
Tichauer, Elliott, Migueis, Lee, et al., 2010). The amplitude term was included in the
fitting to take into account variations in laser power, detection gain and coupling
efficiency (Diop, Tichauer, Elliott, Migueis, Lee, et al., 2010; Ntziachristos & Chance,
2001). To improve the stability of the fitting algorithm, the TPSFs were analyzed for each
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metabolic condition using only µa as a fitting parameter; µ́s and the amplitude scaling
factor were fixed to the values retrieved from the three-parameter fit at baseline. This
approach was reasonable since the metabolic changes only affect blood oxygenation and
not tissue scattering properties. However, in more extreme conditions that could also alter
light scattering, such as large changes in the total hemoglobin concentration (Paunescu et
al., 2001), µ́s could be included as a fitting parameter. The concentrations of oxy- and
deoxy-hemoglobin ([HbO2] and [Hb], respectively) were derived from the measured µa
values using the known wavelength-dependent extinction coefficients and assuming a
cerebral water content of 85% for neonatal pig (Holland, Haas, Norman, Brant-Zawadzki,
& Newton, 1986). Cerebral oxygen saturation, ScO2, was defined as:
ScO =

2.2.4.2

(2.1)

Measuring Absolute CBF by TR NIRS

The methodology underlying the TR NIRS bolus-tracking technique for quantifying
CBF, which is used extensively with imaging modalities such as magnetic resonance
imaging and computed tomography (Wintermark et al., 2005), assumes that the
microvasculature can be modeled as a linear time-invariant system. For this application,
linearity means that the contrast agent concentration in brain tissue is linearly
proportional to the concentration in arterial blood, and time-invariance implies that the
hemodynamic properties must remain constant during the acquisition period. Under these
assumptions, the time-varying concentration of ICG in tissue, Ct(t), is related to the
arterial blood ICG concentration curve, Ca(t), by the convolution operator:
C t = CBF

C t − u R u du

(2.2)

where CBFTR denotes the CBF measurement obtained by the TR NIRS method and R(t)
is the impulse residue function, which represents the fraction of ICG in the tissue at time t
following an idealized unit impulse injection at t = 0 (Zierler, 1965). Ct(t) is determined
from change in µa due to the passage of ICG through the cerebral microvasculature and
Ca(t) was measured by the DDG as outlined in Section 2.2 (Diop, Tichauer, Elliott,
Migueis, Lee, et al., 2010). The flow-scaled impulse residue function, CBFTR • R(t), was
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extracted from Ca(t) and Ct(t) by performing a deconvolution and its initial height equals
CBFTR, since by definition R(0) = 1 (Brown et al., 2002).

2.2.4.3

Measuring Changes in CBF and CMRO2 by TR NIRS

The DCS data from each cerebral metabolic condition were analyzed by the solution to
the correlation diffusion equation for a semi-infinite homogeneous medium assuming
Brownian motion of scatterers (Boas, Campbell, & Yodh, 1995; Boas & Yodh, 1997;
Cheung et al., 2001). The model was fit to the normalized intensity autocorrelation
function (g2) using the µ a and µ́s values obtained by TR NIRS. The fitting parameters
were a scaled diffusion coefficient, which is referred to as the BFI, and a coherence factor
(β) (Diop et al., 2011). The change in the BFI at a given condition relative to baseline,
denoted rCBF, is given by:
rCBF =

(3.3)

The BFI can be converted into units of CBF (ml/100g/min) using the baseline CBF
measurement determined by the TR NIRS bolus-tracking method:
CBF = CBF

· 1 + rCBF

(3.4)

The CMRO2 (ml O2/100g/min) for each metabolic state was determined by conservation
of mass (i.e. the Fick principle), which assumes that the amount of oxygen consumed in
the tissue is equal to the arteriovenous oxygen difference (Siesjo, 1978):
CMRO = CBF ∙ K ∙ tHb ∙ SaO − SvO

(3.5)

where, SaO2 and SvO2 are the arterial and venous oxygen saturations, respectively, K is
the oxygen carrying capacity of hemoglobin (1.39 ml of O2 per g of Hb) (Dominguez de
Villota, Ruiz Carmona, Rubio, & de Andrés, 1981), and [tHb] is the total hemoglobin
concentration. In these experiments, SaO2 was measured by pulse oximetry, [tHb] was
determined from the average of two baseline arterial blood samples and CBF was
determined from the calibrated DCS blood flow measurements. The remaining parameter
SvO2 was determined directly from the sagittal-sinus blood samples and also from the TR

61

NIRS ScO2 measurements. Equation 3.5 neglects the contribution of dissolved oxygen in
plasma, which is reasonable at normal paO2 values (Brown, Hadway, & Lee, 2003;
Elwell et al., 2005). For TR NIRS, SvO2 was determined from ScO2 by assuming the
cerebral blood volume is comprised of a known venous volume fraction (fv) since ScO2
represents the average cerebral blood oxygenation:
SvO =

(3.6)

For this study fv was set to 0.75 (Brun, Moen, & Borch, 1997; Ijichi et al., 2005;
Mchedlishvili, 1986; Watzman et al., 2000) and using Equation 3.6, the Fick principle for
the optical measurements is given by:
CMRO =

2.2.5

∙ ∙

∙ SaO − ScO

(3.7)

Statistical Analysis

Statistical analyses were conducted using SPSS 20.0 (SPSS, Chicago, IL). A repeated
measures analysis of variance (ANOVA) was used to identify significant differences in
SvO2 and CMRO2 between metabolic conditions and between the NIRS and bloodsampling methods. Bland-Altman analysis was used to compare corresponding CMRO2
measurements from the two methods (Altman & Bland, 1983). Post-hoc analyses were
conducted to identify significant differences at each condition, with respect to baseline
values, for all measured parameters. Statistical significance was defined as p < 0.05 and
all data are presented as mean ± standard error of the mean (SEM) unless otherwise
noted. In one animal, measurements were not acquired during the fentanyl/N2Opentobarbital condition, which was corrected for by using the Missing Value Analysis
(MVA) regression algorithm (Graham, 2009).

2.2.6

Error Analysis

A Monte Carlo type approach was conducted to investigate how errors in the baseline
parameters would affect subsequent µa measurements from the one-parameter fitting
routine. First, a theoretical TPSF was generated using the solution to the diffusion
approximation for a semi-infinite homogeneous medium and a set of typical experimental
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values of the scaling amplitude, µa and µ́s (8000, 0.255 cm-1 and 8.62 cm-1, respectively)
(Kienle & Patterson, 1997). The simulated TPSF was convolved with an experimental
IRF and Poisson noise added to reflect typical experimental data. The noisy TPSF was
analyzed by the same non-linear fitting routine used with the experimental data to
generate best-fit estimates of the baseline parameters. Next, another noisy TPSF was
generated using the initial input values, and a one-parameter fit performed to extract an
estimate µa. In this step the values of the amplitude factor and µ́s were set to the estimates
from three-parameter fit. The entire procedure was repeated 5000 times to generate a
distribution of best-fit values for each fitting parameter.
To determine the error in CMRO2 due to uncertainties in the two parameters
measured under each condition (i.e. BFI and ScO2), the SEM of each parameter was
determined from the series of measurements acquired at baseline (i.e. 60 and 288
measurements for BFI and ScO2, respectively). A repeated measures ANOVA was used
to determine the precision of the baseline CBF values measured by the TR NIRS bolustracking method.

2.3 Results
A total of 12 piglets were studied; however, 3 were excluded because the sagittal sinus
was inadvertently punctured during the insertion of the catheter. A puncture caused blood
to leak into the cerebral spinal fluid, resulting in erroneous NIRS measurements of
[HbO2] and [Hb] (Tichauer, Hadway, et al., 2006). One additional experiment was
excluded due to technical errors with the TR NIRS system, which results in incomplete
TPSFs. The average physiological parameters at each metabolic condition from the 8
successful experiments (3 male, 5 female, mean weight = 1.62 ± 0.09 kg, mean age =
1.88 ± 0.35 days) are given in Table 2-1.
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Table 2-1: Physiological parameters during different cerebral metabolic levels
Physiological

Baseline

Fentanyl/N2O

Temperature (°C)

37.8 ± 0.2

37.9 ± 0.1

pH

7.47 ± 0.02

paCO2 (mm Hg)

Fentanyl/N2O

Pentobarbital

Cyanide

37.9 ± 0.2

37.4 ± 0.2

37 ± 0.2*

7.46 ± 0.02

7.46 ± 0.01

7.46 ± 0.01

7.35 ± 0.02*

40.1 ± 0.4

39.6 ± 0.8

38.7 ± 0.7

39.8 ± 0.6

43.3 ± 2.1

paO2 (mm Hg)

124 ± 8

72 ± 5*

76 ± 5*

97 ± 8

135 ± 22

MAP (mm Hg)

42 ± 2

69 ± 2*

82 ± 4*

35 ± 3

27 ± 2*

157 ± 9

241 ± 12*

250 ± 14*

165 ± 11

176 ± 7

Parameter

-1

HR (min )

+ Pentobarbital

pH = arterial pH; paCO2 = partial pressure of carbon dioxide in the blood; paO2 = partial pressure of oxygen
in the blood; MAP = mean arterial blood pressure; HR = heart rate
* p<0.05 compared to parameter value under baseline conditions.
Average ± SEM

Of all the measured parameters, only paCO2 showed no significant differences
between conditions. Blood pH and rectal temperature were significantly different after
injecting sodium cyanide due to the systemic effect of the drug on metabolism.
Significant differences in paO2 were found under the two conditions involving
fentanyl/N2O, which can be explained by a reduction in the inhaled oxygen fraction
during 70% N2O inhalation. Both HR and MAP showed general changes with the
different anesthetics as expected (Siesjo, 1978). The average [tHb] measured under
baseline conditions from the hemoximeter was 8.6 ± 0.8 g/dl. The tissue optical
properties measured under baseline conditions at 760, 802 and 830 nm, were 7.99 ± 0.47,
8.63 ± 0.59, and 8.55 ± 0.86 cm-1 for µ s' and 0.251 ± 0.016, 0.240 ± 0.012, and 0.248 ±
0.009 cm-1 for µ a, respectively.
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Figure 2-2: Measured DCS decay curves during various levels of cerebral
metabolism
A sample of DCS decay curves taken from an experiment collected with a sampling time of 30 seconds and
average count rate of 441 ± 17 kHz. Each curve shown was obtained from the same piglet at a different
induced metabolic condition. The steeper the decay curve the larger the BFI retrieved and ultimately the
faster CBF.

Figure 2-2 shows a sample of DCS intensity autocorrelation curves collected from
each induced metabolic condition during a single experiment. A steeper DCS decay curve
is represented by a larger BFI value, indicating faster blood flow. Typical arterial and
brain ICG concentration curves obtained with the DDG and TR NIRS, respectively, are
shown in Figure 2-3. The derived baseline CBF value obtained from the ICG data sets
were used to calibrate all subsequent BFI values obtained by DCS. The measured CBF
values obtained from the dynamic contrast-enhanced technique ranged from 19 to 50
ml/100g/min with an average of 32 +/- 4 ml/100g/min.
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Figure 2-3: Dynamic contrast-enhanced arterial/tissue time-course curves of ICG
A sample of raw data showing a tissue and an arterial curve measured during the ICG bolus tracking
experiment. The black curve represents the tissue curve measured with the TR NIRS technique whereas the
red curve is the arterial curve obtained from the DDG.

Significant differences were observed in all the BFI values listed in Table 2-2
compared to baseline, except when pentobarbital was injected while under fentanyl/N2O
anesthesia. No statistical significant differences were observed between conditions for the
retrieved baseline β value of 0.157 ± 0.001 which was also in agreement with the
measured value obtained by Diop et al. (Diop et al., 2011). No significant differences
were observed in SaO2 at any of the conditions. A repeated measures ANOVA showed a
significant overall effect by condition for SvO2 [F3,36 = 8.596, Power > 0.99, p<0.01], but
there was no significant effect by technique [F1,14 = 0.007, p>0.9]. Similarly, there was a
significant effect by condition for CMRO2 [F3,36 = 59.707, Power > 0.99, p<0.01], but no
significant effect by technique [F1,14 = 0.014, p>0.9]. These results indicate that the
various conditions altered cerebral energy metabolism, but there were no significant
differences in the SvO2 and CMRO2 measurements between the sagittal sinus blood
measurements and the DCS/NIRS method.
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Table 2-2: NIRS and blood sample measurements
Parameter

Baseline

Fentanyl/N2O

BFI (cm2/s) x 109

61 ± 6

92 ± 10*

SaO2 (%)

99.9 ± 0.1

ScO2 (%)

Fentanyl/N2O

Pentobarbital

Cyanide

62 ± 6

30 ± 5*

28 ± 4*

98.8 ± 0.7

98.7 ± 0.7

99.7 ± 0.6

95.8 ± 2.3

69 ± 2

65 ± 3

61 ± 2

57 ± 3*

59 ± 4

SvO2 – Blood (%)

62 ± 5

55 ± 5

41 ± 5**

42 ± 6**

46 ± 8**

SvO2 – NIRS (%)

58 ± 3

54 ± 4

48 ± 3**

42 ± 4**

46 ± 5**

1.31 ± 0.21

2.25 ± 0.25**

2.01 ± 0.22

0.99 ± 0.18

0.76 ± 0.15**

1.45 ± 0.18

2.41 ± 0.32**

1.81 ± 0.21

0.99 ± 0.17

0.80 ± 0.15**

CMRO2 – Blood
(ml O2/100g/min)
CMRO2 – NIRS
(ml O2/100g/min)

+ Pentobarbital

BFI = blood flow index; SaO2 = saturated arterial oxygen; ScO2 = saturated cerebral oxygen; SvO2 =
saturated venous oxygen; NIRS = near-infrared spectroscopy; CMRO2 = cerebral metabolic rate of oxygen
* p<0.05 compared to parameter value under baseline conditions.
** p<0.05 compared to parameter value under baseline conditions for both techniques combined.
Average ± SEM

Figure 2-4: Mean values of SvO2 and CMRO2 after intake of various
anesthetics/drugs
Average SvO2 and CMRO2 values at each induced condition comparing both techniques. The darker grey
bars represent the NIRS technique, the lighter grey bars represent the blood oxygen sample method, and
the error bars are standard error of the mean. Here * indicates p<0.05 compared to the parameter value
under baseline conditions for both techniques combined.
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Figure 2-4 illustrates the average SvO2 and CMRO2 measurements obtained from
the blood sample and DCS/TR-NIRS techniques under the different conditions.
Measurements were obtained over a range from 25 to 70 % for SvO2 and from 0.3 to 4 ml
O2/100g/min for CMRO2. A Bland-Altman plot of the difference between individual
CMRO2 measurements from the two techniques is shown in Figure 2-5. The mean
difference was 0.027 ml O2/100g/min with limits of agreement (i.e. 95% boundaries) of
0.861 and -0.807 ml O2/100g/min.

Figure 2-5: Bland-Altman analysis of CMRO2
A Bland-Altman plot demonstrating the difference between NIRS and blood oxygen sample CMRO2
measurements plotted against the average. Each colour represents a different piglet. The dotted line
represents the average difference between the two techniques; 0.027 ml O2/100g/min. The solid lines are
the bias lines which represent the region boundaries for which 95% of the differences lie within; 0.027 ±
0.834 ml O2/100g/min.

Figure 2-6 shows the predicted relationship between errors in the baseline optical
properties to the errors in the amplitude factor as determined from the Monte Carlo
simulations. The figure demonstrates that at typical experimental noise levels, µ́s and µ a
were relatively insensitive to errors in the amplitude factor. For example, the error in
either µ́s or µ a was only 6% in the extreme case of a 30% error in the amplitude factor.
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From the Monte Carlo simulations, the coefficient of variation of µa for the oneparameter fitting routine was 1.7%. The small magnitude of this error was also reflected
in the SEM of ScO2 (0.1%) determined from the series of baseline measurements.
Similarly, the SEM of the baseline BFI was 2%. The repeat measurements of absolute
CBF from the bolus tracking method indicated that this was the greatest source of error
with an estimated precision of 11.7%.

Figure 2-6: An error analysis of a three-parameter fit (µa, µ́s, and amplitude factor)
of the diffusion approximation to TR NIRS data
An error analysis comparing the effects of noisy experimental data on a three parameter fit (µa, µ́s, and
amplitude factor) from the diffusion approximation. Black represents µa and red represents µs', while each
data point represents the error in optical properties corresponding to the error in the amplitude factor from
the three parameter fit. The generated noise for 5000 simulated TPSFs had an average variance of 16.41 ±
0.05.

2.4 Discussion
The main finding of this study was that changes in absolute CMRO2 could be measured
by combining two near-infrared techniques: DCS and TR NIRS. This was accomplished
by combining quantitative CBF and SvO2 measurements obtained by a previously
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validated DCS/TR-NIRS approach and multi-wavelength TR NIRS, respectively. The
accuracy of the SvO2 measurements was verified by comparison to direct measurements
of cerebral blood oxygenation obtained from sagittal sinus blood samples. CBF, SvO2
and CMRO2 were measured over a metabolic range from approximately 0.3 to 4 ml
O2/100g/min with no evidence of any level-dependent bias in either the SvO2 or CMRO2
measurements (Figure 2-4 and Figure 2-5). DCS and NIRS have been combined
previously to measure relative changes in CMRO2 (Durduran et al., 2004, 2010; RocheLabarbe et al., 2010, 2012; Zirak, Delgado-Mederos, Martí-Fàbregas, & Durduran,
2010); however, this is the first study to use this combination to quantify CMRO2. The
success of this combined optical approach ultimately depends on the accuracy of the
underlying CBF and ScO2 measurements. A number of studies have demonstrated the
ability of DCS to track relative CBF (Buckley, Cook, Durduran, & Kim, 2009; Carp, Dai,
Boas, Franceschini, & Kim, 2010; Diop et al., 2011; Kim et al., 2010; Zhou et al., 2009).
In particular, Zhou et al., reported a strong correlation between changes in CBF measured
by DCS compared to those measured by fluorescent microspheres in newborn piglets
(Zhou et al., 2009). Similarly, we previously reported a strong correlation between CBF
measurements obtained by the bolus-tracking TR NIRS technique and the BFI
determined from DCS (R2 = 0.93) (Diop et al., 2011).
In our previous study, a single pulsed laser was used to measure the absorption
changes caused by the flow of ICG through brain tissue (Brown et al., 2002).
Determining [HbO2] and [Hb], and thereby ScO2, requires measuring the tissue optical
properties at multiple wavelengths. For this purpose, the TR system was expanded to
three pulsed lasers, and time multiplexing was used to acquire the corresponding three
TPSFs within the same time window (Contini et al., 2006). The disadvantage of this
approach is a lower count rate per channel due to the reduced pulse repetition rate (29.3
compared to 80 MHz); however, for steady-state oxygenation measurements this was not
a concern as the SNR can be improved by increasing the integration time. To quantify the
wavelength-dependent µ a and µ́s values, the IRF was measured for each laser at similar
count rates to those obtained experimentally. Temporal drift and variations in the laser
pulse width (i.e. jitter) are potential sources of error when measuring tissue optical
properties by TR NIRS (Ntziachristos & Chance, 2001). To minimize the former, every
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experiment was preceded by a 1.5 h delay to allow sufficient time for the TR NIRS
system to stabilize in order to avoid instrument drift during the course of an experiment
(Diop, Tichauer, Elliott, Migueis, & Lee, 2010). The results displayed in Figure 2-6
indicate that the baseline µ a and µ́s values could be determined with reasonable accuracy
even if there were large fluctuations in the amplitude factor, such as due to jitter. A
possible improvement to the system would be to correct for both drift and jitter by
acquiring reference data throughout the experiment (Tichauer et al., 2011).
The precision of CMRO2 will depend on the uncertainties in the baseline optical
properties, CBF and ScO2. The Monte Carlo simulations demonstrated that the
uncertainties in the optical properties were small for noise levels typical of the
experimental TPSFs and had little effect on subsequent µa values determined from the
one-parameter fitting routine. These predictions were in good agreement with the SEM of
ScO2 (0.1%) determined from the series of TPSFs acquired during the 5-min baseline
period. Errors in CBF determined by the calibrated DCS approach will depend on the
precision of both the baseline CBF determined by the bolus-tracking method and the
relative BFI obtained by DCS. From repeat bolus injections at baseline, the precision of
the former was estimated to be 11.7%, which is similar to the value determined
previously (9.7%) with a continuous-wave NIRS system (Brown et al., 2002). In these
experiments, the SEM of the BFI was less than 2% due to the large number of
acquisitions obtained in each condition. A variability of less than 5% would still have
been achieved if the acquisition time had been reduced to 5 min (i.e. 10 measurements).
Maintaining the same precision at shorter acquisitions would require increasing the
number of detectors (Buckley et al., 2009; Dietsche et al., 2007), as only a single SPCM
was used to acquire the DCS data in these experiments. In addition to the uncertainties in
the measurements parameters, the accuracy of the CMRO2 measurements will depend on
the assumed value of the cerebral venous blood volume fraction (fv). The need to assume
a value is a common limitation with CMRO2 measurements obtained by NIRS and
positron emission tomography (Elwell et al., 2005; Mintun, Raichle, Martin, &
Herscovitch, 1984; Tichauer, Hadway, et al., 2006). The good agreement between the
NIRS CMRO2 measurements and the values derived from sagittal-sinus blood samples
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(Figure 2-5) indicate that the assumed value of 75% is reasonable. However, any
variation in fv across animals or subjects will clearly reduce the accuracy of the
measurements. It may be possible to circumvent this potential source of error by using
NIRS spiroximetry to measure venous oxygen saturation (Franceschini et al., 2002).
The retrieved µ́s values at baseline were similar with Diop et al. and Ijichi et al.
(Diop et al., 2011; Ijichi et al., 2005). However, the average µ a at 802 nm was greater than
the values given in the two previous studies: 0.2 ± 0.009 cm-1 (Diop et al., 2011) and
0.189 ± 0.005 (Ijichi et al., 2005). The cause of this difference is uncertain; however, the
average ScO2 value (69 ± 2 %) was similar to baseline values previously reported in
piglets (Fantini et al., 1999; Kurth, McCann, Wu, Miles, & Loepke, 2009; Kusaka et al.,
2002; Springett, Newman, Cope, & Delpy, 2000). In addition, the SvO2 values
determined from the absorption changes at the different metabolic conditions ranging
from 25 to 70% were in good agreement with the corresponding SvO2 values measured
directly from sagittal sinus blood samples (Table 2-2, Figure 2-4). Both sets displayed the
same trend in venous oxygenation as cerebral metabolism was initially increased under
fentanyl/N2O anesthesia and subsequently decreased with successive injections of
pentobarbital.
The overall agreement between CMRO2 measurements derived from TR NIRS
and sagittal sinus SvO2 values is similar to our previous validation study, which was
conducted using newborn piglets, but involved a broadband CW NIRS system (Tichauer,
Hadway, et al., 2006). In that study, the mean difference between the two techniques was
0.006 ml O2/100g/min and the 95% confidence interval was ± 0.74 ml O2/100g/min. The
latter is slightly smaller than the boundaries shown in Figure 2-5. However, this
difference can be explained by the outlier that had an average CMRO2 difference greater
than the 95% confidence interval. Removing this point reduced the range to ± 0.704 ml
O2/100g/min, in excellent agreement with the previous results. It is interesting that the
overall trends reported in the two studies were in good agreement considering the
different approaches used to quantify cerebral blood oxygenation. The CW NIRS spectral
data from the previous study were characterized by second derivative spectroscopy,
which can only estimate [Hb] and not [HbO2] since the latter has no definitive features in
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the derivative spectrum (Matcher, Cope, & Delpy, 1993). Consequently, CMRO2 was
determined by normalizing [Hb] by the cerebral blood volume. This step is not required
for TR NIRS since both [Hb] and [HbO2] are determined from the measured optical
properties. A further advantage to directly measuring µ a and µ́s by TR NIRS is these
values can also be used in the analysis of DCS data rather than assuming known values.
Another advantage with TR NIRS is its superior depth sensitivity, which could prove
useful when adapting these optical technologies to measuring CBF and CMRO2 in adult
patients (Elliott, Diop, Tichauer, Lee, & St. Lawrence, 2010; Liebert, Wabnitz,
Steinbrink, Obrig, & Mo, 2004).
Although both studies demonstrate similar agreements between the NIRS and
sagittal sinus CMRO2 measurements, there was a large difference in the initial baseline
CMRO2 values between the two studies: 1.48 ± 0.17 ml O2/100g/min in the current study
and 2.60 ± 0.28 ml O2/100g/min from Tichauer et al. (Tichauer, Hadway, et al., 2006).
One possible explanation is the difference in baseline anesthetics in the two studies.
Baseline measurements in the current study were acquired using a higher concentration of
isoflurane (1.75-2% compared to 1.5%), which will reduce cerebral energy metabolism.
Another contributing factor could be the difference in CBF measurements from CW and
TR NIRS techniques. Previously, we have demonstrated that the CBF values from TR
NIRS underestimated the CW NIRS values, although the reason for this difference was
unclear (Diop, Tichauer, Elliott, Migueis, Lee, et al., 2010). Adjusting the current
CMRO2 values for this difference would increase the mean baseline value to 2.00 ± 0.22
ml O2/100g/min, which is still below our previous results. Most likely, the overall
difference between the two studies is a combination of both factors.
In addition to the different anesthetics, measurements were also conducted after
administering sodium cyanide. This drug was used to alter cerebral oxidative metabolism
by an alternative means, namely, the inhibition of mitochondrial cytochrome oxidase.
Overall, the agreement between the DCS/TR-NIRS and sagittal sinus CMRO2 values
under this condition was similar to that observed under the different anesthetics.
However, the metabolic effect of cyanide was smaller than expected based on a previous
study involving newborn piglets (C. Cooper et al., 1999). This muted effect is likely a
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result of injecting the sodium cyanide while the animals were under the deepest
anesthetic (pentobarbital plus isoflurane). Nevertheless, cyanide did cause a small
reduction in CMRO2, which was observable by both techniques.
A potential limitation with the current study is that the CBF measurements
obtained by the calibrated DCS technique were used to convert both the sagittal-sinus and
NIRS venous oxygenation measurements into CMRO2. Consequently, any systemic error
in the optical CBF measurements would not be observed in this study. We previously
demonstrated a very strong correlation between relative flow changes measured by DCS
and CBF values measured by TR NIRS with a slope from the linear regression of 1.05
(Diop et al., 2011). This comparison was conducted over a range of CBF values from 17
to 90 ml/100g/min, which is very similar to the range observed in the current study.
However, more validation studies would be required if the combined DCS/TR-NIRS
approach were used to measure CMRO2 under pathological conditions such as during
ischemia or severe hypoxia that could result in greater changes in either CBF or SvO2
(Ijichi et al., 2005; Tichauer, Brown, et al., 2006).

2.5 Conclusion
In summary, this study demonstrated that the combination of DCS and TR NIRS can be
used to measure CMRO2, as verified by the comparison to CMRO2 values derived from
cerebral venous blood samples. Experiments were conducted using piglets because they
are similar in size to human newborns and, therefore, the DCS/TR-NIRS system could be
used in clinical studies. Adapting this approach to the neonatal intensive care unit will
require synchronizing the two optical systems to provide truly continuous CBF and
CMRO2 measurements. Extending this approach to adult patients represents a significant
challenge as it requires depth-resolved techniques, such as the use of multi-layered
modeling approaches, to measure CBF, cerebral oxygenation and the BFI accurately
(Gagnon, Desjardins, Jehanne-Lacasse, Bherer, & Lesage, 2008; Jaillon et al., 2006;
Wabnitz et al., 2010). Incorporating sensitivity functions for the different tissue layers
into the analysis of bolus tracking data has been shown to improve the accuracy of CBF
measurements in animal models; however, clinical studies will require validating this
approach in human subjects (Elliott, Diop, Lee, & Lawrence, 2012; Elliott et al., 2010).
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Chapter 3

3

Measurements of Cerebral Blood Flow in Pigs by
Diffuse Correlation Spectroscopy on the Exposed
Cortex

This chapter is adapted from the paper entitled “Assessment of the best flow model to
characterize diffuse correlation spectroscopy data acquired directly on the brain” by
Verdecchia K, Diop M, Morrison L, Lee T-Y, St. Lawrence K, published in Biomedical
Optics Express, vol. 6(11) pp. 4288-4301 (2015).

3.1 Introduction
Near-infrared spectroscopy (NIRS) methods based on the quantification of light
absorption at specific wavelengths have been developed for measuring key physiological
parameters, such as tissue perfusion, blood volume and oxygenation (Boas &
Franceschini, 2011; Durduran & Yodh, 2014; Mesquita et al., 2011). For example, blood
flow can be measured by manipulating arterial oxygenation saturation or injecting a lightabsorbing contrast agent (Diop, Verdecchia, Lee, & St Lawrence, 2011; Kyle Verdecchia,
Diop, Lee, & St. Lawrence, 2013; Weigl et al., 2014); however, these techniques only
enable single time-point measurements. An alternative approach that provides continuous
blood flow monitoring is diffuse correlation spectroscopy (DCS) (Durduran & Yodh,
2014). This method indirectly measures changes in blood flow by monitoring light
intensity fluctuations caused by the movement of erythrocytes in tissue (Boas, Campbell,
& Yodh, 1995; Ninck, Untenberger, & Gisler, 2010). More specifically, the propagation
of photons through extravascular tissue, where they endure multiple scattering events that
randomize their direction, and within vessels, which contain moving erythrocytes,
induces decorrelation of the light that manifests as intensity fluctuations. Blood flow is
assessed by characterizing light intensity decorrelation using a model that describes the
movement of erythrocytes.
Currently, the most common approach for analyzing DCS data is by modeling
erythrocyte motion as a Brownian diffusion-like process, which has previously been
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shown in various species (swine, rodent and human) to provide a better characterization
of the normalized temporal intensity autocorrelation function than the expected random
flow model (RFM) (Binzoni & Martelli, 2015), which describes the motion of erythrocytes
as ballistic (Carp, Dai, Boas, Franceschini, & Kim, 2010; Diop et al., 2011; Kim et al.,
2010; Yu et al., 2007; Zhou et al., 2007). To explain this unexpected finding, Carp et al.
proposed a hybrid model, referred to as the hydrodynamic diffusion model (HDM), that
accounts for both the possibility of multiple light-scattering events within a vessel,
characteristic of diffusive motion, and light-scattering events across vessels,
characteristic of random ballistic motion (Carp et al., 2011). Furthermore, Carp et al.
demonstrated that the DCS measurements are best fit by the HDM for data acquired on
premature newborns (Carp et al., 2011).
Although DCS has been shown to be a promising tool for blood flow monitoring,
the most appropriate flow model for characterizing perfusion is still debatable. The
purpose of the current study was to compare the ability of the three flow models to
characterize DCS data acquired directly on the exposed cerebral cortex of juvenile pigs.
This approach removes signal contributions from the extracerebral tissues (scalp and
skull) that can alter the shape of DCS autocorrelation curves due to partial volume errors
caused by tissue heterogeneity (Gagnon, Desjardins, Jehanne-Lacasse, Bherer, & Lesage,
2008). In addition, cerebral blood flow (CBF) was independently measured by computed
tomography perfusion (CTP) for comparison to the flow estimates obtained by each of
the three flow models.

3.1.1

Diffuse Correlation Spectroscopy

To assess dynamics of light scatterers, DCS measures the normalized intensity
autocorrelation function, g2(ρ,τ) given by (Cheung, Culver, Takahashi, Greenberg, &
Yodh, 2001):
g ρ, τ ≡

〈

,
〈

,
, 〉

〉

(3.1)

82

where <I> , ρ and τ represents the average detected intensity, the source-detector distance
(SDD) and the correlation time, respectively. Equation 3.2 is related to the electric field
autocorrelation function by the Siegert relation (Lemieux & Durian, 1999):
g ρ, τ = 1 + β

|

, |2
, 〉

〈

(3.2)

where, β is the coherence factor of the detection channel and G1(ρ,τ) is the electric field
autocorrelation function. Previously shown, G1(ρ,τ) satisfies a diffusion equation (Boas et
al., 1995; Boas & Yodh, 1997). Assuming a point light source with unit intensity, the
analytical solution to the correlation diffusion equation for a semi-infinite homogeneous
medium is given by (Cheung et al., 2001; Diop et al., 2011; Durduran, Choe, Baker, &
Yodh, 2010):
G ρ, τ =

−

(3.3)

Where, r1 = [ρ2+(z0)2]1/2, r2 = [ρ2+(z0+2zb)2]1/2, zb is the effective depth of the source, and
zb = 2D(1+Reff)/(1-Reff) is the distance above the tissue surface at which the fluence
vanishes, where D is the diffusion coefficient given as (3µ s')-1 and Reff is the effective
reflection coefficient calculated to be 0.493 for the refraction indices of tissue and air
(Haskell et al., 1994). Furthermore, in Equation 3.3, µ D is given by:
μ τ =

μ + αμ k 〈r τ 〉

(3.4)

The coefficients µ a and µ́s are the absorption and reduced scattering coefficient,
respectively, k0 is the wavenumber of light in the medium, α is the proportion of moving
scatters (predominantly red blood cells) to all scatterers and is related to the blood
volume, and <∆r2(τ)> is the mean-square displacement of the moving scatterers during a
correlation time τ. In the analysis of measured g2(ρ,τ), the specific expression for
<∆r2(τ)> is given by one of the following flow models.
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3.1.2

Random Flow Model

The RFM is based on the assumption that photon scattering events associated with motion
occur from scatterers that are uncorrelated (i.e. in separate vessels). In this case, the
mean-square displacement is given by:
〈Δr τ 〉 = V τ

(3.5)

where, V is the velocity of the moving erythrocytes. The product αV2 is referred to as the
random blood flow index (BFIR).

3.1.3

Brownian Diffusion Model

The Brownian diffusion model (BDM) assumes incoherent motion caused by multiple
interactions of moving scatterers, such as erythrocytes within the same vessel. It is the
most commonly used model in DCS analysis and the Brownian displacement formula is
given by:
〈Δr τ 〉 = 6D τ

(3.6)

where, DB is the effective diffusion coefficient, and αDB is referred to as the Brownian
blood flow index (BFIB).

3.1.4

Hydrodynamic Diffusion Model

Carp et al. proposed using the Langevin formula for red blood cell mean squared
displacement to account for the occurrence of both Brownian and random flow motion
(Carp et al., 2011):
〈Δr τ 〉 = 6D

τ − τ 1 − exp −

(3.7)

required to establish diffusive motion. Unlike the Brownian diffusion model, τc accounts
for possible ballistic motion at short delay times. For the HDM, the two fitting parameters
are τc and αDH, the hydrodynamic blood flow index (BFIH).
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3.2 Methods
3.2.1

Experimental Procedure

Animal experiments were conducted in accordance with the guidelines of the Canadian
Council of Animal Care (CCAC) and approved by the Animal Use Committee at Western
University. Juvenile pigs (~6 weeks old) were obtained from a local supplier on the day
of the experiment. Following anesthetic induction with 5% isoflurane, the animals were
tracheotomized and mechanically ventilated on a mixture of oxygen and medical air. A
catheter was inserted into a femoral artery for blood gas analysis. After surgery, the
isoflurane was reduced to 3-4% and the animal was transported to the computed
tomography (CT) suite where the experiments were conducted using a portable
NIRS/DCS system.
The animal was placed prone on the bed of the CT scanner on top of a heated
blanket used to maintain rectal temperature between 38 and 39 ºC throughout the
experiment. To place the optical probes directly on the brain, a rectangular piece of scalp
tissue (~10 cm2) located laterally to the midline on the right hemisphere was first excised.
A caustic pencil was used to cauterize the incised scalp tissue to prevent bleeding. Lastly,
a handheld dremel was used to drill two burr holes, which were the size of optical fibers,
into the skull parallel to the midline. Care was taken to ensure that the dura mater was not
punctured by the dremel. Contact pressure on the dura was minimized since the fibers fit
tightly in the holes, which carried their weight. Furthermore, the distance to the dura
could be measured on the CT images (Figure 3-1) and used to guide the distance that the
fibers were inserted. The burr holes were 7 mm apart, with the exception of one animal
for which the separation was 20 mm. A scout CT scan with an anatomical marker on top
of the skull was used to define the location of the burr holes.
Following surgery, the emission and detection fibers were placed in the posterior
and anterior burr holes, respectively. The head of the pig was covered by an opaque
blanket to reduce ambient light contamination. During the experiment, arterial oxygen
saturation, heart and respiration rates, mean arterial pressure, and rectal temperature were
continuously monitored. Arterial blood samples were obtained to measure arterial pH,
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partial carbon dioxide tension (paCO2), partial oxygen tension (paO2) and blood glucose
(BG) concentration. Samples were acquired before and after each set of measurements to
assess physiological stability during the data acquisition period. Intermittent dextrose
injections were administered to maintain normal BG levels (between 5 and 7 mmol/L).
Two sets of CT, time-resolved (TR) NIRS, and DCS data were acquired in each
experiment: first at normocapnia (paCO2 between 38 and 42 mmHg) and then at
hypocapnia (paCO2 between 20 and 25 mmHg). Each capnic level was maintained by
adjusting the ventilation volume and rate. The sequence of data acquisition during
normocapnia consisted of CT perfusion, TR NIRS measurements of optical properties
and DCS. For the hypocapnic condition the sequence of data acquisition was reversed in
order to avoid removing the optical probes from the burr holes between the two
conditions.

3.2.2

Computed Tomography

The dynamic CT protocol consisted of a bolus injection of 1.0 mL/kg of iodine-based
contrast agent (iopamidol [370-Isovue®], Bracco S.p.A., Milan, Italy) at a rate of 3 mL/s
into the cephalic vein once during each capnic condition. The first five animals were
scanned by a Lightspeed QXi multislice scanner (General Electric Company, Waukesha,
WI) and the last three animals were scanned by the Revolution CT scanner (General
Electric Company, Waukesha, WI) due to scanner availability. Each scan (slice thickness
= 2.5 mm, current = 200 mA, energy = 80 kVp, FOV=140×140×40 mm) provided sixteen
coronal slices, once every second, for a period of 40 s. The field of view covered the
entire head of the pig. Functional maps of CBF were calculated using the clinical CT
perfusion software package (PERFUSION 5, General Electric Healthcare Worldwide),
which was developed and validated in house (Cenic, Nabavi, Craen, Gelb, & Lee, 1999).
Region of interest (ROI) analysis was performed using an in-house developed software
that performed pixel thresholding to remove signal contributions from large vessels that
can lead to overestimation of CBF (Murphy et al., 2006). Five sequential slices between
the burr holes that were visible on the anatomical CT images were chosen as they
correspond to the “banana-shaped” path of the near-infrared light between the emission
and detection optical fibers, as seen in Figure 3-1. For each slice, an ROI (~5 cm
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diameter) was drawn on the cerebral cortex near the skull, since NIRS is most sensitive to
superficial tissue. The CBF values were obtained by averaging over the ROIs in the five
slices.

Figure 3-1: Single slice of the exposed cortex of a pig: perfusion map and anatomical
CT images
A CT image of a single slice for a blood flow map (A) and the corresponding anatomical map (B). The ROI,
shown in black for A and white for B, was manually drawn on the superficial cortex using in-house software.
The burr hole, which exposed the cortex and held the optical fiber, is identified by the white arrow.

3.2.3
3.2.3.1

Optical Methods
Time-Resolved NIRS

The TR NIRS systems consisted of a picosecond pulsed diode laser (LDH-P-C 764,
PicoQuant, Germany) emitting at 764 nm, with an average output power and pulse
repetition rate of 1.4 mW and 80 MHz, respectively. The light was attenuated using
electronically controlled variable neutral density filters (NDC-50C-4M, Thorlabs) and
coupled to a multimode emission fiber used for both DCS and TR NIRS (emission probe:
N.A. = 0.22, core = 400 µm; Fiberoptics Technology, Pomfret, CT). A 2-m fiber (N.A. =
0.22, core = 400 µm; Fiberoptics Technology, Pomfret, CT) was used to detect light at a
SDD of 7-mm. The TR NIRS detection fiber was coupled to a fast hybrid photomultiplier
detector with Peltier cooling (PMA Hybrid, PicoQuant, Germany). The output of the
detector was sent to a multichannel picosecond event timer and time-correlated singlephoton counting (TCSPC) module (HydraHarp 400, PicoQuant, Germany). The system
was given at least a 2-hour warmup period to stabilize the laser and detection system
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before acquiring data (Verdecchia, Diop, Lee, & St. Lawrence, 2015). Under each capnic
condition, a distribution of times of flight of photons (DTOF) was recorded for 30
seconds. At the end of the study, the instrument response function (IRF) was measured to
account for systemic temporal dispersion (Ntziachristos & Chance, 2001).
Tissue optical properties (µa and µ́s) were acquired for each condition to reduce
inter-subject variability when extracting blood flow indices from DCS (Diop et al., 2011;
Irwin et al., 2011). A three-parameter fitting routine, described in detail elsewhere (Diop
et al., 2010), was used to extract estimates of µa, µ́s and an amplitude scaling factor during
normocapnia. The model used to fit the DTOF was the solution of the diffusion
approximation for a semi-infinite homogeneous medium convolved with the measured
IRF. The short SDD was calibrated with a phantom of known optical properties. The
fitting range was set to 95% and 30% of the peak DTOF value for the ascending and
descending sides, respectively. The measured µ́s for normocapnia was fixed when
analyzing the DTOF acquired during hypocapnia to reduce the number of fitting
parameters to µa and amplitude scaling factor.

3.2.3.2

Diffuse Correlation Spectroscopy

The light source of the DCS system consisted of a continuous-wave laser (DL785-100-S,
CrystalLaser, Nevada) emitting at 785 nm with a maximum output power of 100 mW and
a coherence length >5 m. As with the TR NIRS system, the emitted light was attenuated
by electronically controlled variable neutral density filters and coupled to the multimode
emission fiber. A single-mode fiber (SMF-28e+, N.A. = 0.14, length = 4 m, core = 8.2
µm, single-mode cutoff wavelength at 1260 nm) was placed in the anterior burr hole of
the animal and was used for detecting the temporal light intensity fluctuations. The SMF
was tightly wrapped into a 5-cm coil to increase the losses of the higher-order modes
before being coupled to the input-channel of the avalanche photodiode of a single photon
counting module (SPCM-AQ4C, Excelitas Canada Inc, QC, Canada) (Dietsche et al.,
2007; Gisler et al., 1995). The output of the SPCM was sent to a photon correlator board
(DPC-230, Beker & Hickl, Germany) that computed the normalized intensity
autocorrelation functions (g2).
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For each animal, two g2 curves were acquired, one during normocapnia and one
during hypocapnia, over an acquisition period of 90 s. The µa and µ́s measured by TR
NIRS were used in the DCS fitting routine. Each g2 curve was analyzed three times using
the solution of the diffusion approximation for a semi-infinite homogeneous medium
including one of the three flow models (BDM, RFM and HDM). The start and end limits for
the fitting were defined by correlation times of 0.6 µs and 1 ms, respectively. In the
fitting procedure, the coherence factor β was set to the value determined by averaging the
first 10 data points of each g2 curve.

3.2.4

Statistical Analysis

All errors are given as the standard errors of the mean (SEM), unless stated otherwise.
All statistics were computed with the IBM SPSS Statistics 20 software package. For the
measured physiological parameters, a multivariate analysis of variance (ANOVA), which
included pH, paCO2, paO2, cGlu, ctHb, MAP, HR, temperature, and SpO2, was computed
to determine significant changes between capnic conditions. For two experiments, the TR
NIRS data set was not experimentally collected due to overheating of the detector and
therefore were determined by the average optical properties of the remaining animals
during normocapnia. For the hypocapnia optical properties, the µa values were estimated
from the average change in absorption from normocapnia to hypocapnia measured by all
animals in this study. A one-way ANOVA compared capnic conditions for measured µa
and BFI values, and, for the former, a post-hoc test [Tukey’s honest significant difference
(HSD)] identified any significant light absorbing outliers between subjects.
A direct comparison between the sums of squares (SS) determined the best fit of
the BDM and RFM, since both models included one fitting parameter. However, the extra
fitting parameter (τc) included in the HDM is expected to reduce the variance in the fit of
the measured g2(ρ,τ). Therefore, an F-test was used to compare whether the
improvements by the HDM to fit the measured g2(ρ,τ) curves, due to the additional fitting
parameter, exceeded the reduction in variance similarly to the approach used by Carp et
al. (Carp et al., 2011). The degree of freedom used in the F-test was determined by the
number of correlation bins that the individual fit required, which was 164. For the HDM to
better characterize the data compared to either the BDM or the RFM, the calculated F-
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number had to exceed a critical F-value of 3.9, as determined by the finv function in
MATLAB (Mathworks, Natick, MA) for a p<0.05.
Linear regression analysis was performed to assess the correlation between CBF
measured by CTP, and the blood flow index obtained by each of the three DCS models
and τc for the HDM. A Bland-Altman plot was used to assess the difference in the percent
flow reductions measured by DCS and CTP (Altman & Bland, 1983). For the BlandAltman plot, a one-sample t-test identified differences between the two modalities (DCS
and CTP), and a linear regression was used to determine any proportionality bias.

3.3 Results
3.3.1

Physiological Parameters and Optical Properties

Eleven juvenile pigs (ten females, one male) were used in the study with an average
weight of 16.0 ± 0.7 kg; however, only nine animals were scanned by CTP due to limited
access to the CT scanner for the first two experiments.
Table 3-1: Physiological parameters during normocapnia and hypocapnia
*paCO2

paO2

ctHb

MAP

HR

[mmHg]

[mmHg]

[g/dL]

[mmHg]

[bpm]

7.45 ± 0.01

40.2 ± 0.3

182 ± 11

10.2 ± 0.3

43.6 ± 1.9

128 ± 8

7.62 ± 0.02

22.1 ± 0.4

213 ± 12

9.8 ± 0.4

38.1 ± 1.9

121 ± 7

Condition

*pH

Normocapnia
Hypocapnia

Note: Data are presented as average ± SEM. paCO2, partial pressure of carbon dioxide in the blood; paO2,
partial pressure of oxygen in the blood; MAP, mean arterial blood pressure; HR, heart rate.
* p<0.05 between conditions.

Table 3-1 lists the physiological parameters measured during normocapnia and
hypocapnia. A multivariate ANOVA indicated significant differences between capnic
conditions for blood pH [p<0.001, partial-η2=0.84, power=1.00] and arterial carbon
dioxide pressure (paCO2) [p<0.001, partial-η2=0.98, power=1.00] as expected. All other
physiological parameters, including BG concentration, temperature and arterial oxygen
saturation, did not change. Their mean values were 4.0 ± 0.2 mmol/L, 38.4 ± 0.1 º°C, and
95 ± 1%, respectively.
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Figure 3-2: Tissue absorption measured by TR NIRS directly on the brain
Average µa values for the 10 animals included in this study and the µa value of the excluded outlier.
Absorption values are presented for normocapnic (black) and hypocapnic (grey) conditions. The large µa for
the outlier was attributed to excessive blood in the emission burr hole. Error bars represent the SEM.

Figure 3-2 presents the average µ a values measured by TR NIRS during
normocapnia and hypocapnia. No significant difference between the two conditions was
observed

[p>0.55,

partial-η2=0.02,

power=0.09].

Following

surgery,

visible

hemorrhaging in the emission burr hole was observed in one animal, which resulted in
high µa values, as confirmed by a Tukey HSD post-hoc analysis (Figure 3-2).
Consequently, the data from this animal were removed from further analysis, unless
stated otherwise. The mean µ́s for all animals was 10.7 ± 1.3 cm-1.
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Figure 3-3: Hemodynamics measured by CTP and DCS during normocapnia and
hypocapnia
Measured flow by (A) CTP (N = 9) and (B) DCS using the BDM (N = 10), during normocapnia and
hypocapnia. The line of best fit and CI95% are represented by the dashed red line and blue lines,
respectively.

Figure 3-3 presents CBF values measured by CTP and the BFIB derived from the
DCS data, both plotted as a function of paCO2. The outlier identified in Figure 3-2 was
excluded from the DCS data. The results from the BDM are presented since it is the model
most commonly used to analyze DCS data. Regression analysis resulted in a slope of 1.4
± 0.20 mL/min/100g/mmHg (CI95%: 0.94, 1.8, p<0.001), an intercept of 7.1 ± 6.6
mL/min/100g (CI95%: -6.8, 21.1, p>0.29) and correlation coefficient (R) of 0.86 for CBF
versus paCO2. Likewise, the line of best fit from Figure 3-3B had a slope of (1.2 ± 0.3) x
10-9 cm2/s/mmHg [CI95%: (0.45, 1.86) x 10-9, p<0.003], an intercept of (1.7 ± 10.9) x 10-9
cm2/s [CI95%: (-21.2, 24.6) x 10-9, p>0.88] and R of 0.63.
Table 3-2 lists the mean CBF values measured by CTP and corresponding BFI
values derived from the DCS data using each of the three flow models. All values (CBF,
BFIB, BFIR and BFIH) were significantly different (p<0.05) between the two capnic
conditions.
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Table 3-2: Hemodynamic parameters measured by CTP and DCS during
normocapnia and hypocapnia
Condition

*CBF

*BFIB
-9

2

*BFIR
-3

2

*BFIH
-9

2

*τc

[mL/min/100g]

[10 cm /s]

[10 cm /s]

[10 cm /s]

[µs]

Normocapnia

62.5 ± 2.5

47.6 ± 4.9

37.2 ± 8.0

70.0 ± 8.2

2.72 ± 0.34

Hypocapnia

37.7 ± 2.6

27.9 ± 4.1

12.5 ± 3.3

38.2 ± 6.4

3.52 ± 0.29

Note: Values represent the average ± SEM. CBF, cerebral blood flow quantified by CTP; BFIB, blood flow
index determined by the Brownian flow model; BFIR, blood flow index determined by the random flow model;
BFIH, blood flow index determined by the hydrodynamic flow model; τ , the time scale for the randomization
of velocity vectors associated with RBC scattering events.
* p<0.05 between conditions.

Included in Table 3-2 is τc from the HDM, which was also significantly different
(p<0.05) between conditions. Not given in Table 3-2 are the average value of β, which
was 0.152 ± 0.002 for all models; no significant differences were observed between
capnic conditions.
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3.3.2

Example of the Best-Fit of the Flow Models

Figure 3-4 shows normalized intensity autocorrelation curves obtained on the exposed
cerebral cortex of one animal during normocapnia (blue) and hypocapnia (red).

Figure 3-4: Measured DCS decay curves acquired during normocapnia and
hypocapnia
DCS autocorrelation curves during normocapnia (red dots) and hypocapnia (blue dots) from one animal.
Also shown are the best-fit to the three DCS flow models: BFIB (solid line), BFIR (dotted line) and BFIH
(dashed line). Data were acquired with a count rate of ~600 kHz for a total acquisition time of 30 seconds.
To visually enhance the differences between the fits of the three models, a portion of the graph is displayed
that focuses on correlation times between 2 to 12 µs, which encompass the initial decay of the measured
intensity autocorrelation functions.

The normalized intensity autocorrelation curves decayed faster during
normocapnia than during hypocapnia, reflecting the higher blood flow in the former
condition. For the example shown in Figure 3-4, the blood flow reductions measured by
BFIB, BFIR and BFIH were 48.9%, 74.0% and 50.0%, respectively. Figure 3-4 illustrates
the poor fit of the RFM model. A statistical analysis by the F-test, as was described earlier,
indicated that the fit of the HDM was significantly better than for the BDM for all
autocorrelation curves. No differences were observed in the extracted BFI values by
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including more of the tail component of the correlation curves in the fitting routine (data
not shown).
To further investigate the fits of the three DCS flow models, Figure 3-5 presents
continuous BFI values during the transition from normocapnia to hypocapnia. The BFI
was determined from autocorrelation curves generated every two seconds. The flow
reductions measured by the three models were 34.1%, 54.6% and 34.6% for the BDM,
RFM and HDM, respectively.

Figure 3-5: Real-time change of BFI measured during the transition from
normocapnia to hypocapnia directly on the brain
Real-time change in BFI measured during the transition from normocapnia to hypocapnia in one pig. DCS
data were acquired at a count rate of 780 ± 3 kHz and analyzed by each flow model. The dashed line
represents the end of the normocapnic period before the respirator was adjusted to induce hypocapnia.

3.3.3

Computed Tomography Perfusion Comparison

Linear regression between the CBF change measured by CTP and the corresponding BFI
change measured by each of the three DCS models was conducted on eight experiments
after the outlier was removed (Figure 3-2). Also, linear regression between the CBF
change measured by CTP and τc was conducted. The resulting regression slopes,
intercepts and R-values are listed in Table 3-3.
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Table 3-3: Linear relationship between CTP and corresponding DCS indices from
different flow models
Parameter

Units

Slope (CI95%)

Intercept (CI95%)

R-value

BFIB

cm2/s

*1.03 ± 0.23 (0.54, 1.52)

-13.9 ± 12.1 (-39.9, 12.1)

0.78

BFIR

cm2/s

*1.24 ± 0.33 (0.52, 1.95)

-36.8 ± 17.7 (-74.8, 1.1)

0.70

2

BFIH

cm /s

*1.66 ± 0.36 (0.89, 2.44)

-27.9 ± 19.1 (-68.9, 13.0)

0.78

τc

µs

*-0.030 ± 0.015 (-0.061, -0.001)

*4.86 ± 0.76 (3.24, 6.48)

0.46

Note: BFIB, blood flow index determined by the DCS Brownian flow model; BFIR, blood flow index
determined by the DCS random flow model; BFIH, blood flow index determined by the DCS hydrodynamic
flow model; CI95%, 95% confidence intervals. Estimated slope and intercept (± SEM) for linear regression
between CTP and BFI for each flow model along with the correlation coefficient (R) and p-values calculated
by SPSS. * represents coefficients that are significantly different (p<0.05) from the null.

Table 3-3 demonstrates that the BFI values from each of the three models were
correlated with CBF measured by CTP as indicated by a slope significantly different
(p<0.01) from the null but a y-intercept not significantly different from zero. The
displacement time constant τc, from the HDM also correlated with CBF, but its R-value
was not as strong and the y-intercept was significantly different from the zero.
Figure 3-6 presents the relative CBF decrease from normocapnia to hypocapnia as
measured by CTP and DCS. The box-plot presents the results from all three DCS flow
models, whereas only the results from the BDM are presented in the Bland-Altman plot. In
Figure 3-6A, the average CBF change measured by CTP was -39.7 ± 3.7%, which was
only significantly different from the change in BFIR (-63.2 ± 4.7%) and not from the BFI
changes measured by the other two models (-41.0 ± 4.3% for BFIB and -44.2 ± 5.0% for
BFIH). In Figure 3-6B, the mean difference between BFIB and CTP, indicated by the solid
line, was 9.0 ± 5.1%, which was not significant (CI95%: -19.1 and 37.0, as indicated by
the two solid lines).
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Figure 3-6: Comparison between the percent difference of CBF measured by CTP
and different DCS flow models acquired on the exposed cortex of pigs
Flow percent differences measured by CTP and DCS directly on exposed cortical tissue. (A) Box plots of the
reductions in flow from normocapnia to hypocapnia measured by CTP (N = 9) and the three DCS flow
st
rd
models (N = 10). The center line, box edges, error bars, and the cross represents the median, 1 and 3
quartiles, CI95%, and outliers, respectively. (B) Bland-Altman plot comparing the reductions in CBF measured
by CTP and BFIB (N = 8). Each symbol represents a single animal. The mean difference between the two
modalities, the standard error of the mean, and the CI95% are indicated by the solid line, the dotted line and
the dashed line, respectively.

In Figure 3-6B the animals that did not undergo CTP and the optical outlier for
DCS were removed due to listwise deletion. For clarity, Table 3-4 summarizes all of the
pigs in this study with their acquired modalities (CTP, TR NIRS and DCS) and SDD.
Table 3-4: A summary of all animals with acquired modalities.
Animal Number

CTP

TR NIRS

DCS

SDD [mm]

1

No

Yes

Yes

7

2

No

Yes

Yes

7

3

Yes

No (Unstable System)

Yes

7

4

Yes

No (Unstable System)

Yes

7

5

Yes

Yes

Yes

7

6

Yes

Yes

Yes

20

7

Yes

Yes

Yes

7

8*

Yes

Yes

Yes

7

9˟

Yes

Yes

Yes

7

10

Yes

Yes (Identified Outlier)

Yes (Removed Outlier)

7

11^

Yes

Yes

Yes

7

Note: ˟, * and ^ represents the animal used in Figure 3-1, Figure 3-4 and Figure 3-5, respectively. An
unstable TR NIRS system occurred by an overheated detector prior to acquisitions. The identified outlier
was described in detail above by Figure 3-2.
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3.4 Discussion
The main aims of this study were to assess which DCS flow model best characterized
‘brain’ autocorrelation curves and to compare measured flow reductions obtained with
the different models to an independent measure of CBF. These experiments were
conducted with the optical probes placed directly on the exposed cortex in order to collect
DCS data without any signal contamination from extracerebral tissues. To verify that the
interrogated cortical region was relatively homogeneous with regards to blood flow, the
autocorrelation curves were re-analyzed using only the early portion (i.e. between
correlation times of 0.3 and ~10 µs) since this range is considered more sensitive to
deeper propagating photons (Selb et al., 2014). No significant differences in blood flow
indices were observed compared to the larger range of correlation times (0.6 µs to 1 ms)
used in the Methods section, indicating that it was reasonable to consider the exposed
cerebral cortex as a homogeneous medium (Verdecchia, Diop, & St. Lawrence, 2015).
Of the three models used to characterize normalized intensity autocorrelation
functions, the hybrid model, HDM, which accounts for both diffusive and ballistic motion,
provided the best fit as determined by the F-test. This was evident at early correction
times, which represents the transition from the ballistic to diffusion regime (Figure 3-4).
This finding is in agreement with Carp et al., who found that the HDM provided a superior
fit to DCS data acquired from premature infants (Carp et al., 2011). The additional
constant τc, which represents the time scale to transition from ballistic to diffusive
motion, was found to be significantly greater (~29%) at hypocapnia compared to
normocapnia. This inverse relationship with CBF would be expected considering that
within a given period fewer interactions between RBCs within a vessel would occur as
flows decreases. Despite the better fit provided by the HDM, differences in blood flow
indices from this model and the more commonly used BDM were small. No significant
differences were observed between the two models in terms of absolute BFI values and
relative changes. This agreement indicates that the ballistic range of photons detected by
DCS is relatively small, suggesting that most detected photons undergo correlated
scattering events (i.e. scattering events occurring within a single vessel).
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A practical limitation with using the HDM is the addition of an extra fitting
parameter, τc, which leads to a greater sensitivity to noise in the measured autocorrelation
curves. This was demonstrated visually by the continuous monitoring example shown in
Figure 3-5, in which data were acquired every two seconds. To characterize the noise
sensitivity of each model, the coefficient of variation of the BFI over the baseline period
was computed. The coefficient for BFIH was 38.5% larger than for BFIB. Furthermore,
the linear regression analysis between the blood flow indices and CBF measurements
from CTP showed less uncertainty and a tighter confidence interval range for the BDM
than the HDM (Table 3-3). Therefore, the BDM model, which is more robust and provides
similar BFI measurements to the HDM, is the more practical model to use, particularly for
data with a lower signal-to-noise ratio, such as the real-time DCS monitoring displayed in
Figure 3-5.
For the second aim of this study, CTP was used to measure CBF at normocapnia
and hypocapnia. The latter causes a substantial reduction in CBF because of the tight
coupling between cerebrovascular tone and arterial blood carbon dioxide tension.
Hypocapnia rather than hypercapnia was used in these experiments because decreases in
blood flow are clinically relevant to the management of critical care patients due to the
incidence of delayed cerebral ischemia. Flow reductions caused by hypocapnia are not as
great as caused by ischemia; however, the good agreement with the CTP results is further
evidence of the ability of DCS to measure CBF changes accurately. The cerebral vascular
reactivity measured with the BDM was (-2.3 ± 0.2)% per mmHg of paCO2, which is in
good agreement with our previous study, which used the same animal model (juvenile
pigs) and a contrast-enhanced NIRS technique to measure CBF (Elliott et al., 2014).
Likewise, these findings confirm previous validation studies involving both animal
models and human subjects that have shown a good correlation between BFIB and CBF
changes measured by other modalities (Yu et al., 2007; Zhou et al., 2006). Considering
that the DCS data in the current study were collected directly on the brain, this agreement
is evidence that DCS is relatively insensitive to extracerebral signal contamination in
applications in which the scalp and skull are thin. These would include animal models,
such as piglets and rats (Carp et al., 2010; Diop et al., 2011), but more importantly, also
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applies to newborns (Diop, Kishimoto, Toronov, Lee, & Lawrence, 2015; Jain et al.,
2014).
A possible limitation with this study is the potential for CTP to overestimate CBF
due to the presence of pixels with extremely high flow estimates. These ‘vascular’ pixels
are attributed to high contrast enhancement in vessels and were removed in the current
study by setting perfusion thresholds (Murphy et al., 2006). This procedure has been
shown to significantly improve the correlation with CBF measurements from positron
emission tomography (Kudo et al., 2003) and from magnetic resonance imaging (Koziak,
Winter, Lee, Thompson, & St. Lawrence, 2008). Another potential limitation was the
possibility of variations in CBF between measurements from the different modalities. To
minimize this, paCO2 was monitored frequently to ensure it remained stable during each
capnic level.

3.5 Conclusion
In summary, contributions from the superficial layers (scalp and skull) were eliminated
by exposing the cerebral cortex of juvenile pigs and acquiring DCS directly on the brain.
In agreement with Carp et al., the flow model that demonstrated the best fit to the
intensity autocorrelation functions was the hybrid flow model, as evident at early
correlation times. However, BFI values from the BDM and the HDM were very similar and
both were in agreement with the CBF changes measured by CTP, indicating that the
diffusion-like flow of erythrocytes dominates. Furthermore, the BDM is the more practical
model for characterizing DCS data due to its greater robustness.
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Chapter 4

4

Measurements of Cerebral Blood Flow in Adolescent
Pigs by Diffuse Correlation Spectroscopy

This chapter is adapted from the paper entitled “Assessment of a multi-layered diffuse
correlation spectroscopy method for monitoring cerebral blood flow in adults” by
Verdecchia K, Diop M, Morrison L, Lee T-Y, St. Lawrence K, published in Biomedical
Optics Express, vol. 7(9) (2016).

4.1 Introduction
Patients requiring intensive care due to life-threatening neurological emergencies, such as
ischemic stroke, traumatic brain injury and subarachnoid hemorrhage, are at high risk of
secondary brain injury (De Oliveira Manoel et al., 2015; English et al., 2013; Kirkman,
Citerio, & Smith, 2014). Although multiple factors contribute to poor outcome, a major
focus is preventing delayed cerebral ischemia. For example, approximately one-third of
patients with subarachnoid hemorrhage will develop secondary brain injury within two
weeks of the initial event primarily due to cerebral vasospasm (Al-Tamimi, Orsi, Quinn,
Homer-Vanniasinkam, & Ross, 2010). Consequently, a major focus of neurointensive
care is maintaining adequate cerebral blood flow (CBF) through treatments such as
administering nimodipine, inducing hypertension, and intervening with surgical or
pharmacological angioplasty (Macdonald, 2014). A key component of patient
management is the use of monitoring techniques to detect signs of impaired CBF, such as
elevated flow velocities in cerebral arteries as measured by transcranial Doppler.
However, this is not a direct measure of CBF and cerebral ischemia can occur without
evidence of arterial narrowing (Dhar et al., 2012). Cerebral blood flow can be monitored
directly by thermal diffusion and laser Doppler flowmetry (Kirkpatrick, Smielewski,
Czosnyka, & Pickard, 1994; Vajkoczy et al., 2000), but these are invasive methods,
which has hindered their wider applicability. To date, there remains no established
bedside technique capable of monitoring CBF.
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Near-infrared spectroscopy (NIRS) is a portable, non-invasive technology that can
be used to monitor cerebral oxygenation at the bedside of critical-care patients (Obrig &
Steinbrink, 2011; Zweifel et al., 2010). Cerebral blood flow can be measured directly
using the optical dye indocyanine green as an intravascular contrast agent (Brown et al.,
2002; Steinkellner et al., 2010; Weigl et al., 2014). With the application of light
propagation models to account for absorption in extracerebral tissues, this contrastenhanced approach can also provide quantitative CBF measurements (Elliott et al., 2014),
but it is limited to single time point measurements. An alternative approach is diffuse
correlation spectroscopy (DCS) that monitors changes in CBF by detecting speckle
patterns caused by the motion of red blood cells (Baker et al., 2014; Boas, Campbell, &
Yodh, 1995; Buckley, Parthasarathy, Grant, Yodh, & Franceschini, 2014). A normalized
intensity autocorrelation curve is determined from the measured temporal speckle pattern,
and a blood flow index is obtained by fitting the autocorrelation curve with an analytical
solution to the correlation diffusion equation for a semi-infinite homogeneous medium
(Cheung, Culver, Takahashi, Greenberg, & Yodh, 2001). A number of validation studies
involving alternative methods of measuring blood flow have shown that DCS can track
perfusion changes in the brain accurately (Buckley et al., 2014; Durduran & Yodh, 2014).
Modeling DCS data in this manner is reasonable if contributions from extracerebral
tissues are small such as for neonates and certain animal models (Buckley et al., 2014;
Diop, Kishimoto, Toronov, Lee, & Lawrence, 2015; Lin et al., 2013). However in the
adult head, reflected light measured on the scalp must travel through more substantial
extracerebral layers (i.e. scalp and skull), leading to partial volume errors and
underestimations of CBF.
A number of approaches have been proposed to account for tissue heterogeneity
when applying DCS to monitor CBF in adults, starting with the use of a correction factor
based on partial volumes estimates (Durduran et al., 2004). Another approach is to weight
the model fit to shorter correlation times since these represent longer photon pathlengths
(i.e. photons that have a greater chance of having propagated deeper into tissue) (Baker et
al., 2015; Selb et al., 2014). However, these methods can only enhance the sensitivity to
CBF but do not completely separate the effects of light propagation and blood flow in the
various tissues. A more direct approach is to adapt a multi-layered solution to the
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diffusion approximation that accounts for the contribution of the extracerebral layers.
Using Monte Carlo simulations and layered tissue phantom, this approach has been
shown to improve the sensitivity to CBF (Gagnon, Desjardins, Jehanne-Lacasse, Bherer,
& Lesage, 2008), and it has been used to analyze DCS data acquired from participants
performing a functional task (Li et al., 2005). These studies highlight the importance of
using a theoretical model that accounts for extracerebral tissue layers to improve
sensitivity to cerebral tissue when analyzing DCS data acquired on the adult head.
The current study investigates the application of a multi-layered (ML) DCS model
to data acquired at multiple source-detector distances with the aim of separating brain and
scalp blood flow. Two sets of experiments were conducted to assess the improved depth
sensitivity of the ML modeling approach. First, a two-layered tissue-mimicking phantom
was constructed in which the pseudo-flow property of each layer could be independently
altered. Data were acquired at two source-detector distances while the diffusion
coefficient in the deeper layer was gradually increased. Second, the approach was applied
to measuring CBF in a juvenile swine model, which was chosen because the thickness of
the extracerebral layers is similar to that of the adult human head. Cerebral blood flow
was reduced by altering blood CO2 tension from normocapnia to hypocapnia. For
validation, CBF was independently measured by computed tomography perfusion (CTP)
(Elliott et al., 2014; Lee, 2002).

4.2 Theory
With DCS, the measured temporal intensity fluctuations are used to compute the
normalized intensity autocorrelation function, g2(ρ,τ) (Cheung et al., 2001):
g ρ, τ ≡

〈

,
〈

,
, 〉

〉

(4.1)

where, <I(ρ,t)> is the light intensity measured by a detector located at a distance ρ from
the source at time t, and τ is the correlation time. Equation 1 is related to the electric field
autocorrelation function, G1(ρ,z,τ) ≡ <E(ρ,z,τ) • E*(ρ,z,t+τ)>, by the Siegert relation
(Lemieux & Durian, 1999):
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g ρ, τ = 1 + β

|

〈

, , |
, 〉

(4.2)

where, β is the coherence factor of the detection system. It has been shown for a high
scattering, low-absorbing medium, such as tissue, that G1(ρ,z,τ) can be modeled by the
correlation diffusion equation at a depth z in the medium (Boas et al., 1995; Skipetrov &
Maynard, 1996). By modeling the medium as a series of parallel slabs over a semiinfinite medium, the diffusion equation is given by (Boas et al., 1995; Skipetrov &
Maynard, 1996):
P ∇ −μ

τ G ρ, z, τ = − Sδ

−

(4.3)

where, Pi = v/(3µ ai + 3µ́si) is the photon diffusion coefficient in layer i, v is the speed of
light, µ ai is the absorption coefficient and µ́si is the reduced scattering coefficient. S is the
light source defined at an effective depth z0 (= 1/µ́s1) by the delta function δ

−

.

Finally, µPi accounts for the loss of correlation due to dynamical processes (i.e. the
motion of scatterers) and is given by:
μ

τ =

μ + 2μ k αD τ

(4.4)

where, k0 = 2πn/λ is the wavenumber of light (λ is wavelength and n is the refractive
index, which is set to 1.4 for all tissues), α represents the fraction of scattering events
related to motion, which in tissue represents the fractional blood volume, and Di is the
diffusion coefficient of the ith layer. If blood flow is modeled as a pseudo-Brownian
process (Cheung et al., 2001), which is valid for brain (Verdecchia, Diop, Morrison, Lee,
& St. Lawrence, 2015), then the blood flow index, Fi, is given by αDi.
Modeling tissue as a semi-infinite homogeneous medium, the analytical solution
to Equation 4.3 is given as [16,18]:
G ρ, z, τ =

−

(4.5)

where, r1 = [ρ2 + z02]½, r2 = [ρ2 + (z0 + 2zb)2]½, and zb is the extrapolated boundary defined
by 2P1(1 + Reff)(1 – Reff)-1 (Kienle & Glanzmann, 1999). The effective reflection
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coefficient, Reff, is given by 0.493 for the refraction indices of tissue and air (Haskell et
al., 1994). In the general case consisting of parallel slabs on a semi-infinite medium, the
field autocorrelation function at the surface (i = 0), G s, z, τ , can be determined by
solving Equation 4.3 in the Fourier domain (Li et al., 2005):
G s, z, τ =

G ρ, z, τ e

d ρ

(4.6)

Similar to Li et al., the appropriate boundary conditions were applied to G ρ, z, τ , which
is obtained by numerically computing the inverse Fourier transform of G s, z, τ at the
surface (Gagnon et al., 2008; Li et al., 2005):
G ρ, z, τ =

G s, z = 0, τ sJ sρ ds

(4.7)

where s is the radial spatial frequency, J0 is the Bessel function of zeroth order computed
by the MATLAB function besselj and the solution of G s, z, τ . The Hankel transform in
Equation 4.7 was computed numerically by rearranging the solution for a three-layered
model to the form of the Gauss-Laguerre quadrature in MATLAB:
G s, z, τ =

(4.8)

numerator = S 0, z − z
×z

μ P cosh μ

L −z

μ P cosh μ L

+ μ P sinh μ L
+ μ P sinh μ

L −z

μ P cosh μ L

+ μ P sinh μ L
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denominator = μ P cosh μ L

μ

cosh μ L

+ sinh μ L

μ P +μ P z

+ sinh μ L

μ

+ sinh μ L

μ P +μ μ P P z

P +μ P z

cosh μ L μ P P + μ P z

where, µ̃Pi2(s,τ) = µPi2(τ) + s2 for the ith layer, and L1 and L2 are the thicknesses of the first
and second tissue layers (i.e. scalp and skull, respectively); the third layer is brain, which
is assumed to be infinitely thick.

4.3 Methods
4.3.1

Instrumentation

4.3.1.1

Hybrid Optical System

The light source of the DCS instrument was a continuous-wave laser (DL785-100-S,
CrystalLaser, Nevada) emitting at 785 nm with a maximum output power of 100 mW and
a coherence length >5 m. The emitted light was attenuated by electronically controlled
variable neutral density filters and coupled to a multimode emission fiber (N.A. = 0.22,
core = 400 µm; Fiberoptics Technology, Pomfret, CT). Twelve single-mode fibers (SMF28e +, N.A. = 0.14, length = 4 m, core = 8.2 µm, single-mode cutoff wavelength at 1260
nm) were split into separate fiber bundles located at source-detector distances (SDDs) of
20 and 27 mm. Due to the considerable drop in light intensity with distance, one fiber
was placed at 20 mm and the remaining 11 were placed at 27 mm. Each fiber was
coupled to the input of a single photon counting module (SPCM-AQ4C, Excelitas
Canada Inc). The output of each SPCM was sent to a 16-channel photon correlator board
(DPC-230, Beker & Hickl) that computed the normalized intensity autocorrelation
functions, g2(ρ,τ).
Tissue optical properties (i.e. µa and µ́s) were measured by a TR NIRS system
described in detail elsewhere, (Diop et al., 2010; Verdecchia et al., 2015). Briefly, the
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instrument consisted of a picoseconds pulsed diode laser (LDH-P-C 764, PicoQuant,
Germany) emitting at 764 nm with an average output power and pulse repetition rate of
1.4 mW and 80 MHz, respectively. The light was guided by the same type of optical fiber
as the DCS emission probe; the two probes were bundled together to emit light at the
same location. The pulsed light was detected by 121 optical fibers (core = 200 µm,
cladding = 220 µm, N.A. = 0.22, length = 0.5 m), which were bundled together with the
11 DCS single-mode detection fibers located at the SDD of 27 mm. Collected photons
were guided to a fast hybrid photomultiplier detector (PMA Hybrid, PicoQuant,
Germany) whose output was sent to a time-correlated single-photon counting (TCSPC)
module (HydraHarp 400, PicoQuant, Germany). At the end of the study, the instrument
response function (IRF) was measured to account for instrument-related temporal
dispersion (Ntziachristos & Chance, 2001).

4.3.1.2

Computed Tomography Perfusion

All CT imaging was performed with a Revolution CT scanner (General Electric
Company, Waukesha, WI). Perfusion images were acquired by performing a dynamic
contrast-enhanced protocol, which involved serial acquisition of image volumes, one
acquired every second, for 40 seconds (200 mA, 80 kVp, 2.5-mm slice thickness, and a
FOV of 140 x 140 x 40 mm). Each volume consisted of 32 coronal slices, which
encompassed the entire head. The beginning of the dynamic scanning was immediately
followed by a bolus injection of 1.0 mL/kg of iodine-based contrast agent (iopamidol
[370-Isovue®], Bracco S.p.A., Milan, Italy) at a rate of 3 mL/s into the cephalic vein.

4.3.2
4.3.2.1

Experimental Procedure
Two-Layered Diffusion Phantom Experiment

A two-layered phantom was designed using computer-aided 3D drawing software
(Rhinoceros 5; Robert McNeel & Associates, North America). It was constructed from
dark polyvinyl chloride (12 mm thick) and had internal dimensions of 180 x 140 x 110
mm. Two layers were created by inserted a polyester Mylar sheet (polyethylene
terephthalate; McMaster-Carr) with a thickness of 25.4 µm. The Mylar sheet was framed
by a clear polycarbonate that could be positioned at a depth of either 5 or 10 mm from the
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top of the box. Three holes were drilled into the top of the box to hold the probes in
place: one emission fiber and two detection fibers at SDDs of 20 and 30 mm. To mimic
the light scattering properties of tissue, both layers were filled with 0.8% Intralipid
(Fresenius Kabi, Germany). The viscosity in the bottom layer was increased by adding
methyl cellulose (4000 cP; Sigma-Aldrich, St. Louis, MO) (Cheung et al., 2001).
To replicate the homogeneous condition, DCS data were first acquired at a SDD
of 30 mm and multiple cellulose concentrations (0, 0.05, 0.1, 0.15, and 0.2%), but
without the Mylar membrane. In addition to acquiring DCS data, µa and µ́s were
measured by TR NIRS at each cellulose concentration. Next, the membrane was inserted
to create a top layer with a thickness of 5 or 10 mm. DCS data were acquired at 20 and 30
mm while increasing the cellulose concentration in the bottom layer from 0 to 0.2%, but
maintaining the top-layer concentration at 0%. Data acquired with the homogeneous
phantom were analyzed by the analytical solution (Equation 4.5) for the homogeneous
model (DCSHM). Data acquired with the two-layered phantom were analyzed with
DCSHM (SDD = 30 mm) and ML DCS method using data from both separations.

4.3.2.2

Animal Experiments

Experiments were conducted under the guidelines of the Canadian Council of Animal
Care (CCAC) and approved by the Animal Use Sub-Committee at Western University.
The animals were obtained from a local supplier on the day of the experiment. Following
anesthetic induction with 5% isoflurane, the animals were tracheotomized and
mechanically ventilated on a mixture of oxygen and medical air. A catheter was inserted
into a femoral artery for blood gas analysis. After surgery, isoflurane was reduced to 34% and the animal was transported to the CT suite where the experiments were
conducted.
Before data collection, CT scout images were acquired to determine the best
location for the probe holder on the head (i.e. the position corresponding to the largest
brain diameter). During the experiment, arterial oxygen saturation, heart rate (HR),
respiratory rate, mean arterial pressure (MAP), and rectal temperature were continuously
monitored. Arterial blood samples were obtained to measure arterial pH, the arterial
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partial pressure of carbon dioxide (paCO2), the arterial partial pressure of oxygen (paO2),
the concentration of blood glucose (BG), and the total blood hemoglobin concentration
(ctHb). Samples were acquired before and after each set of measurements to assess
physiological stability during data acquisition. The order for the three modalities was
CTP, TR NIRS, and DCS at normocapnia (paCO2 between 38 and 42 mmHg) and
reversed at hypocapnia (paCO2 between 20 and 25 mmHg) to avoid removing the DCS
probes from the head between measurements. Each capnic level was maintained by
adjusting the ventilation volume and rate. To investigate if the multi-distance DCS
measurements were affected by scalp blood flow, the acquisition protocol was repeated
after creating incisions in the scalp around three lateral sides of the probe holder to
reduce scalp blood flow (Elliott et al., 2014).

4.3.3
4.3.3.1

Data Analysis
Computed Tomography Perfusion

Maps of CBF were calculated using the CT perfusion software package PERFUSION 5
(GE Healthcare Worldwide), which was developed and validated in-house (Cenic,
Nabavi, Craen, Gelb, & Lee, 1999). Region-of-interest (ROI) analysis was performed
using in-house developed software that performed pixel thresholding to remove signal
contributions from large vessels that can lead to CBF overestimations (Murphy et al.,
2006). For each slice, three ROI’s (~5 cm2) were manually drawn on the scalp, skull, and
cerebral cortex, as seen in Figure 4-1. The location of the scalp ROI was located laterally
to the actual positions of the DCS probes. This was done to avoid motion artifacts near
tissue interfaces such as bone and scalp caused by breathing. The brain ROI was drawn
on the cerebral cortex since the NIRS signal is more sensitive to superficial brain tissue
than deeper white matter. Absolute blood flow values for each of the three tissues (scalp,
skull and brain) were obtained by averaging ROIs across ten to twelve sequential slices.
Finally, the thicknesses of the scalp and the skull (i.e. L1 and L2, respectively) were
measured by image-viewing software (AW VolumeShare 4, GE Healthcare).
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Figure 4-1: Single slice of the intact head of a pig: anatomical and perfusion map
CT images
Coronal CT image of a pig’s head (A) and the corresponding blood flow map (B). The scalp (1), skull (2) and
brain (3) ROIs are shown in white. Bar codes are given to illustrate relative x-ray attenuation (A) and blood
flow in mL/min/100g (B).

4.3.3.2

Diffuse Correlation Spectroscopy

All intensity autocorrelation functions were acquired over an integration time between 30
and 90 s depending on the achieved count rate. Measured g2(ρ,τ) functions were
converted to the field autocorrelation function by Equation 4.2. Data were analyzed using
both solutions to the diffusion approximation: the semi-infinite homogeneous model
(Equation 4.5) and the ML model (Equations 4.6 and 4.7). Estimates of the diffusion
coefficients were determined using a non-linear least squares fitting routine (MATLAB©
function fminsearchbnd with Di values constrained to be positive) to fit an analytical
model to g2(ρ,τ). For the homogeneous model, data from one SDD were analyzed to
generate a diffusion coefficient for the tissue-mimicking phantom or a blood flow index
denoted FHM for the in vivo data. These values were derived using the values of µa and µ́s
measured by TR NIRS, which were also determined by the solution to the diffusion
approximation for a semi-infinite homogeneous medium (Diop, Verdecchia, Lee, & St
Lawrence, 2011). The fitting was performed for correlation times from 1 µs up to times
corresponding to g1(ρ,τ) > 0.5, since focusing the fit of the autocorrelation function to
short correlation times increases the sensitivity to deeper propagating photons (Selb et al.,
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2014). For the animal experiments the g2(ρ,τ) functions acquired at 20 and 27 mm were
analyzed separately and denoted FHM,1 and FHM,2, respectively.
For the ML DCS model, the g2(ρ,τ) functions acquired at the two SDDs were
analyzed simultaneously. The µ a and µ́s values for all three layers were set to the values
obtained from TR NIRS using the homogeneous model, and L1 and L2 values were
obtained from the CT images. For each animal, the coherence factor (β) was estimated
prior to the fitting by averaging the first five points of each autocorrelation function. To
focus on deeper propagating photons, the fitting was performed between correlation times
defined by g2(ρ,τ) < 0.8 to 0.1 s for the shorter SDD (20 mm), and 1 µs to g2(ρ,τ) > 0.5
for the longer SDD (27 mm). For the flow phantom, the two fitting parameters were the
diffusion coefficients in the top and bottom layers (DT and DB, respectively). Similarly,
the fitting parameters for the analysis of the in vivo data were the blood flow indices in
scalp and brain (denoted FS and FB, respectively), assuming negligible flow in the middle
(skull) layer.

4.3.3.3

Statistical Analysis

Uncertainties are given as the standard error of the mean unless otherwise stated. All
statistics were computed with the IBM SPSS Statistics 20 software package. For the
phantom experiments, linear regression analysis was conducted to identify a significant
relationship between increasing viscosity in the bottom layer and the measured diffusion
coefficients (DT and DB).
For the animal experiments, possible changes in the measured physiological
parameters and optical properties due to altering paCO2 or the scalp incisions were tested
by a repeated measures analysis of variance (ANOVA). The same test was conducted on
all measured flow parameters, which include the blood flow estimates for scalp, skull and
brain measured by CTP, and for the blood flow indices measured by DCS techniques: FS
and FB from the ML DCS analysis, and FHM,1 and FHM,2 from the homogeneous model.
Relative blood flow changes measured by CTP and ML DCS when paCO2 was altered
from normocapnia to hypocapina were compared by a paired t-test. Finally, BlandAltman analysis was conducted to compare the reductions in CBF and FB obtained by
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CTP and ML DCS, respectively. This included a one-sample t-test to identify differences
between the two modalities and linear regression to determine proportionality bias.

4.4 Results
4.4.1

Phantom Experiments

Figure 4-2 illustrates the relative change (i.e. from 0% cellulose) in the estimated
diffusion coefficient from the homogeneous model (A) and the ML DCS model (B) as the
viscosity in the bottom layer of the phantom was increased by adding cellulose. In the
latter case, the diffusion coefficient from the bottom layer (DB) is shown. For
comparison, each graph also includes the measured change in the diffusion coefficient for
the homogeneous phantom.

Figure 4-2: Relative change in the measured diffusion coefficient from the deepest
layer of a multi-layered phantom: analyzed by homogeneous and heterogeneous
DCS flow models
Relative change in the measured diffusion coefficient as the viscosity of the tissue-mimicking phantom was
increased. The label ‘expected’ refers to the homogeneous case (blue bars), and the labels ‘5 mm’ and ‘10
mm’ refer to thickness of the top layer for the two-layered case (red and green bars, respectively). For the
two-layered experiments, cellulose was only added to the bottom layer. (A) Diffusion coefficient determined
by analyzing the two-layered data with the homogeneous model (SDD = 30 mm). (B) Diffusion coefficient for
the bottom layer of a two-layered model applied to the same data used in (A). This analysis used data
acquired at SDD of 20 and 30 mm.
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The results in Figure 4-2A were obtained using the HM-DCS model to
characterize the g2(ρ,τ) curves acquired at a SDD of 30 mm, and as expected the
magnitude of the error was larger as the top layer thickness increased. The results in
Figure 4-2B were obtained using the ML DCS model to characterize g2(ρ,τ) acquired at
SDDs of 20 and 30 mm. Linear regression analysis indicated that increasing the viscosity
in the bottom layer significantly reduced DB, but had no effect on DT for either a 5 or 10
mm thick top layer. The optical properties measured by TR NIRS in the homogeneous
phantom were µ a = 0.033 ± 0.003 cm-1 and µ́s = 8.5 ± 0.2 cm-1.
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4.4.2

Animal Experiments

4.4.2.1

Physiological Experiments

Experiments were conducted on seven pigs (all female) with an average weight of 15.5 ±
0.4 kg and average scalp and skull thicknesses of 3.5 ± 0.2 mm and 6.4 ± 0.4 mm,
respectively. For all physiological parameters, significant differences were observed preand post-scalp incision, except for pH, paCO2 and paO2.
As expected, significant differences between normocapnia and hypocapnia were
observed for pH and paCO2 [p<0.001, partial-η2 > 0.98, Power = 1]; however, a
significant change in paO2 and MAP were also observed [p<0.05, partial-η2 > 0.69,
Power > 0.85] (see Table 4-1). Significant changes were not observed for any of the other
measured physiological parameters. Their mean values were 38.4 ± 0.1 °C (temperature),
120 ± 2 beats per minute (HR), 5.3 ± 0.2 mmol/L (BG) and 9.2 ± 0.1 g/dL (ctHb). Lastly,
no differences were observed in µa (0.168 ± 0.008 cm-1) and µ́s (9.0 ± 0.8 cm-1) between
capnic conditions.
Table 4-1: Physiological parameters during normocapnia and hypocapnia
Condition

*pH

*paCO2 (mmHg)

*paO2 (mmHg)

*MAP (mmHg)

Normocapnia

7.473 ± 0.006

39.5 ± 0.4

173 ± 10

41 ± 1

Hypocapnia

7.658 ± 0.006

22.2 ± 0.4

210 ± 10

38 ± 1

Average values at normocapnia and hypocapnia for the arterial partial pressure of carbon dioxide (paCO2,)
and oxygen (paO2). * p<0.05 between conditions. Data are presented as average ± SEM.

4.4.2.2

Absolute Blood Flow

Five blood flow index sets (FS and FB) measured by ML DCS out of a total of 28 were
removed due to either a large residue (i.e. > 0.01) in the optimization procedure (two
cases) or an FB value that approached zero (i.e. < 10-9) (one case). Lastly, both sets of
g2(ρ,τ) curves (i.e. during normocapnia and hypocapnia) from one experiment were
removed due to poor coupling between the optical probes and skin.
Normalized intensity autocorrelation curves from one experiment are plotted in
Figure 4-3. This set was chosen as the FB values at normo- and hypo-capnia were similar
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to the average values across all animals. The shift to longer correlations times from
normocapnia to hypocapnia evident in Figure 4-3 represents a -38.7 % flow change
measured by ML DCS.

Figure 4-3: Measured DCS decay curves acquired on the intact head of a pig during
normocapnia and hypocapnia
Normalized intensity autocorrelation functions acquired during normocapnia (red curve) and hypocapnia
(blue curve) at SDD of 20 mm (A) and 27 mm (B) with count rates of ~465 and ~55 kHz, respectively. The fit
of the ML DCS model is illustrated by the black curve.

No significant changes in any of the blood flow indices (i.e. FS and FB values
from the ML DCS analysis and FHM from the HM-DCS analysis) were found by
comparing values pre and post scalp incisions. This unexpected finding was likely due to
increased variability in the DCS signal due to probe pressure effects since it was
necessary to remove the fibers to perform the incisions (Mesquita et al., 2013).
Consequently, capnic data before and after scalp incision were grouped together in all
subsequent analysis. Note, SBF measured by CTP did not change with scalp incisions
since the scalp ROI (Figure 4-1) was lateral to probe location to avoid breathing-related
motion artifacts.
Figure 4-4 plots the blood flow estimates obtained by CTP and DCS for the two
paCO2 conditions. Significant differences between normocapnia and hypocapnia were
found for CBF measured by CTP [p<0.001, partial-η2 = 0.984, Power = 1] and FB
measured by ML DCS [p<0.05, partial-η2 = 0.816, Power = 0.685]. Significant
differences were also found for FHM at a SDD of 20 mm [p<0.05, partial-η2 > 0.876,
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Power > 0.852] and a SDD of 27 mm [p<0.05, partial-η2 > 0.826, Power > 0.710]. In
contrast, no significant differences between capnic conditions were found for SBF
measured by CTP, and FS measured by ML DCS. Finally, skull flow measured by CTP
(8.9 ± 0.7 mL/min/100g) and the coherence factors β (0.158 ± 0.001 and 0.168 ± 0.002,
for SDD of 20 and 27 mm, respectively) did not change significantly with paCO2 (data
not shown).

Figure 4-4: Absolute blood flow in the scalp and brain measured by CTP and DCS
during normocapnia and hypocapnia
Scalp blood flow (SBF) and cerebral blood flow (CBF) measured by CT, and the corresponding blood flow
indices measured by DCS during normocapnia (red bars) and hypocapnia (blue bars). All values were
averaged over their pre- and post- scalp incision measurements. FS and FB were obtained from the ML
model analysis of DCS data acquired at SDDs of 20 and 27 mm. FHM was obtained by analyzing data from
each SDD separately with the HM model (FHM,1 refers to 20 mm and FHM,2 refers to 27 mm). Significant
differences observed between capnic conditions are represented by *.

Table 4-2: Mean absolute flow values in the scalp and brain measured by CTP and
DCS during normocapnia and hypocapnia
Capnic

*CBF

*FB
-9

SBF
2

FS
-9

*FHM,1
2

-9

2

*FHM,2

Condition

(mL/min/100g)

(10 cm /s)

(mL/min/100g)

(10 cm /s)

(10 cm /s)

(10-9 cm2/s)

Normocapnia

52.4 ± 1.7

52.3 ± 6.9

18.1 ± 1.5

7.3 ± 2.1

7.1 ± 1.3

7.7 ± 1.1
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Hypocapnia

33.2 ± 1.7

36.3 ± 4.2

19.0 ± 1.2

5.0 ± 1.2

6.0 ± 1.3

6.1 ± 1.0

Average flow values (CBF and SBF, FB and FS) measured by CTP and ML DCS, respectively, for
normocapnic and hypocapnic conditions. Significant differences between capnic conditions are indicated by
*.

A significant Pearson correlation (R = 0.538) was observed between CBF and FB.
Likewise, significant correlations were observed between FS and both FHM,1 (R = 0.972)
and FHM,2 (R = 0.881).

4.4.2.3

Relative Blood Flow

The relative change in CBF and DCS indices when reducing paCO2 from normocapnia to
hypocapnia are presented in Figure 4-5.

Figure 4-5: Comparison between the percent difference of CBF measured by CTP
and different DCS flow models acquired on the skin of the intact head of pigs
(A) Box plot of relative flow change caused by reducing paCO2 from normocapnia to hypocapnia. Flow
values of CBF, FB, FHM,1 and FHM,2 measured by CTP (N = 14), ML DCS (N = 11), DCSHM,1 (N = 14) and
DCSHM,2 (N = 14), respectively. The center line, box edges, error bars, and the cross represent the median,
1st and 3rd quartiles, CI95%, and outliers, respectively. Significant changes compared to CBF are
represented by *. (B) Bland-Altman plot comparing reductions in CBF and FB measured by CTP and ML
DCS (N = 11). The mean difference between the two modalities, the standard error of the mean, and the
CI95% are indicated by the solid line, the dotted line and the dashed line, respectively. Flow change
measured while the scalp tissue was intact or incised is represented by circle and diamond symbols,
respectively.

Mean CBF reduction measured by CTP (−36.4 ± 3.3 %) was not significantly
different from the corresponding FB change (−33.5 ± 4.5 %). In contrast, the FHM,1 change
(-13.2 ± 7.5 %) was significantly different from both the CTP and ML DCS results.
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Similarly, the change in FHM,2 (-19.1 ± 6.0 %) was significantly different from CTP
results and a trend was observed when compared to FB (p = 0.054). A Bland-Altman
analysis comparing relative CBF changes measured by CTP and ML DCS is shown in
Figure 4-5B. The mean difference between the two modalities was -1.2 ± 4.6 % (CI95%: 31.1 and 28.6). Linear regression analysis of the Bland-Altman plot indicted a significant
proportional bias (p<0.001, R = 0.837).

4.4.2.4

Real-Time Flow Monitoring

To demonstrate the ability of ML DCS to resolve dynamic differences in scalp and brain
blood flow, a series of g2(ρ,τ) curves acquired during the transition from normocapnia to
hypocapnia from one experiment were analyzed (Figure 4-6). In this example, the flow
change calculated by the difference between means of the first and last minutes was -42.9
% in the brain and 5.2 % in the scalp. The coefficients of variation for the baseline scalp
and brain time series were 9.8 % and 8.4 %, respectively.

Figure 4-6: Real-time change of scalp and brain BFIs measured during the
transition from normocapnia to hypocapnia
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Blood flow dynamics during the transition from normocapnia to hypocapnia from one experiment. Each
g2(ρ,τ) curve was acquired for 2 seconds and analyzed separately by the ML DCS model to obtain time
series of FB and FS. Data were acquired at a count rate of 554.3 ± 0.4 kHz and 101.5 ± 0.2 kHz at SDDs of
20 mm and 27 mm, respectively. The thickness of the scalp and the skull were 3.7 ± 0.4 mm and 6.0 ± 0.4
mm, respectively.

4.5 Discussion
The aim of this work was to test the ability of a depth-sensitive DCS approach to retrieve
the blood flow index from the brain despite the presence of a substantial superficial tissue
layer. The approach was based on obtaining two autocorrelation functions with varying
depth sensitivities by placing detectors at distances from the source of 20 and 27 mm.
The multi-distance data were then analyzed with a three-layered solution to the
correlation diffusion equation to account for light propagation through scalp, skull and
brain, and the different blood flows in scalp and brain (Li et al., 2005). Rather than fitting
a complete autocorrelation curve, different ranges of correlation times were used to fit the
curves obtained at the two source-detector distances in order to alter the weighting to
shorter or longer photon pathlengths (Farzam & Durduran, 2015; Selb et al., 2014). More
specifically, the range for the longer SDD (27 mm) was restricted to early correlation
times, while longer correlation times were selected for the shorter SDD (20 mm).
The feasibility of the ML DCS approach was first verified using a two-layer
tissue-mimicking phantom in which the diffusion property of the bottom layer was
altered by adding four different cellulose concentrations (Cheung et al., 2001). The
change in the measured diffusion coefficient of the bottom layer, which varied from 20%
to 80% by increasing the cellulose concentration, was in good agreement with the change
observed in the homogeneous phantom over the same concentration range (Figure 4-2).
In contrast, as expected, the diffusion coefficient of the 10-mm thick top layer did not
change when cellulose was added to the bottom compartment (data not shown). In
agreement with Gagnon et al. (Gagnon et al., 2008), these results highlight the ability of a
multi-layered model to resolve differences in flow rates in different layers with minimal
crosstalk between the measured diffusion coefficients.
The second aim of the study was to apply the same ML DCS approach to an
animal model in which CBF was independently measured by CT perfusion. Juvenile pigs
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were selected as the total thickness of their extracerebral tissues was expected to be
similar to that of adult humans. The mean values of scalp and skull thicknesses were 3.5
± 0.2 and 6.4 ± 0.4 mm, respectively, which are within the expected range for humans,
although larger values can be found depending on the location on the head (Strangman,
Zhang, & Li, 2014). Global CBF was reduced by lowering paCO2 from normocapnia to
hypocapnia. Overall, good agreement was found between the average CBF reductions
measured by CTP (36.4 ± 3.3 %) and ML DCS (33.5 ± 4.5 %). The corresponding
estimates of cerebrovascular reactivity (CVR), defined as the change in CBF per unit
change in paCO2, were -1.9 ± 0.2 % per mmHg and -1.7 ± 0.2 % per mmHg for CTP and
ML DCS, respectively. These estimates are in good agreement with our previous studies
involving this animal model: -2.3 % per mmHg from CTP and -2.3 % per mmHg from
DCS probes placed directly on the exposed cerebral cortex (Elliott et al., 2014;
Verdecchia et al., 2015). In addition, good agreement was also found between the
absolute blood flow index determined from ML DCS (Table 4-2: Mean absolute flow
values in the scalp and brain measured by CTP and DCS during normocapnia and
hypocapnia) and our previous values derived from autocorrelation functions measured
directly on the brain, (~48x10-9 cm2/s at normocapnia and ~28x10-9 cm2/s at hypocapnia)
(Verdecchia et al., 2015). This agreement suggests that FB could be used as a marker to
track longitudinal changes in CBF, similar to previous DCS studies involving infants
(Roche-Labarbe et al., 2012). However, this would require careful assessment of the
reproducibility of FB considering the added complexity of the analysis. Intriguingly, the
group-wise variability in FB (~40%) was in good agreement with previous studies in
which the blood flow index was derived from the semi-infinite homogeneous model
(Diop et al., 2011; Verdecchia et al., 2015). This is despite the addition of a scalp blood
flow index (i.e. Fs) in the fitting routine.
Although the results of this study demonstrate that a multi-layered modeling
approach can account for the effects of extracerebral tissue, the accuracy of FB will be
affected by errors in the additional model input parameters (i.e. the thicknesses of scalp
and skull, and tissue optical properties). To assess the sensitivity to uncertainties in the
thickness measurements, the g2(ρ,τ) curves from the tissue-mimicking phantom with a
10-mm top layer were re-analyzed with the top layer thickness varied by ± 20%. The
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resulting error in the diffusion coefficient for the bottom layer was less than 10%, similar
to that reported by Gagnon et al. (2008). In clinical practice, the thicknesses of the scalp
and skull could be obtained from medical images or possibly measured directly using
ultrasound. Alternately, the total scalp/skull thickness could be included as an additional
fitting parameter, similar to an approach proposed for measuring cerebral oxygenation by
multi-distance frequency-domain NIRS (Hallacoglu, Sassaroli, & Fantini, 2013). This
would likely require more SD distances than used in the current study and careful
attention to the shortest SDD in order to avoid violating the Siegert relationship (Binzoni,
Sanguinetti, Van de Ville, Zbinden, & Martelli, 2016). Regarding the optical properties,
all three tissue layers were set to the single µ a and µ́s values measured by TR NIRS since
the primary focus was assessing the ability of DCS to measure changes in CBF, which is
fairly insensitive to uncertainties in absolute µ a and µ́s (Diop et al., 2011; Irwin et al.,
2011). Separate values of µ a and µ́s for each tissue layer could be obtained using a multilayer solution to analyze the TR NIRS data (Diop & St Lawrence, 2013; Liemert &
Kienle, 2013).
An alternative and simpler approach to account for partial volume errors is to
multiply the change in the blood flow index obtained from the homogeneous model by a
correction factor based on the partial pathlength through brain (Durduran et al., 2004;
Gagnon et al., 2008; Selb et al., 2014). Durduran et al. (2004a) initially used a value of 5
based on modeling the head as a two-layered medium. More recently, Selb et al.
proposed a factor of 3 by restricting the fitting to early correlation times. In the current
study, correction factors of 2.4 and 1.8 were found for SDDs of 20 and 27 mm,
respectively, by comparing the mean change in FHM to the CBF change measured by
CTP. Similarly, a factor of 1.5 was determined from the tissue phantom experiments with
a 10-mm thick top layer and a SDD of 30 mm. The smaller values at larger separations
(27 and 30 mm) would be expected given the improvement in depth sensitivity as the
SDD is increased. Although applying a correction factor is simpler than using a multilayered model, high variability across experiments was found. In this study, the
correction factor varied by ± 60% across animals. Furthermore, the similarity between
mean FHM and FS values in Table 4-2: Mean absolute flow values in the scalp and brain
measured by CTP and DCS during normocapnia and hypocapnia indicates that the DCS
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signal is heavily weighted by extracerebral tissue. This sensitivity could lead to erroneous
CBF estimates if scalp blood flow changed due to systemic effects or variations in
surface probe pressure, highlighting the value of a multi-layered model to uncouple brain
and scalp blood flow.
An unexpected finding was the proportional bias revealed by regression analysis
in the Bland-Altman plot (Figure 4-5B) despite similar flow changes measured by CTP
and ML DCS (mean difference = -1.2 ± 4.6 %). This bias remained even after removing
the outlier that had a mean CBF change greater than 50%. One explanation is the
accuracy of the ML DCS approach could be affected by variations in the thickness of the
extracerebral layer; however, no correlation with FB was found. Considering the range of
CBF reductions was limited to between 20 to 40%, this bias should be viewed with
caution. A wider range of flow changes, for instance by including hypercapnia
experiments to increase CBF, would help to assess the validity of the observed bias.
Another unexpected finding was an average perfusion signal in skull of 9 mL/min/100g
measured by CTP. This would appear to contradict the assumption of the ML DCS
method that skull has negligible blood flow. However, this value is likely artificial
considering a similar ‘perfusion’ signal (10 mL/min/100g) was found in the probe holder
(see Figure 4-1B). Likely this artifact is related to greater variability in flow estimates in
areas of extremely low contrast enhancement. It should be noted that there was no change
in skull blood flow between capnic levels.

4.6 Conclusion
In summary, this study demonstrates that DCS has the ability to separate scalp and brain
blood flow, as demonstrated in Figure 4-6, despite the presence of a relatively thick
extracerebral layer (of the order of 1 cm). The ML DCS technique could be further
optimized by incorporating optical property measurements for the different tissue layers
and by improving the SNR through the use of a software correlator to measure only
relevant correlations times (Wang et al., 2016). Recent improvements for monitoring
CBF were demonstrated in the adult head by a pressure modulation algorithm, without
requiring a priori anatomical information (Baker et al., 2015). The approach taken by
Baker et al. could be combined with the multi-layered model presented in this study to
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isolate cerebral signals detected by DCS when estimating extracerebral tissue thickness
by imaging methods is unavailable. Future work will implement a multi-layered
DCS/TR-NIRS hybrid to demonstrate a means of quantifying the cerebral metabolic rate
of oxygen in adults (Elliott et al., 2014; Verdecchia, Diop, Lee, & St. Lawrence, 2013).
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Chapter 5

5

Discussion/Conclusion

The main objective of this thesis was to advance diffuse correlation spectroscopy (DCS)
techniques with the long-term aim of assessing cerebral hemodynamics and metabolism
in the intensive care unit (ICU). Typically, near-infrared spectroscopy (NIRS) measures
tissue oxygen saturation but it also can measure CBF using an optical dye as an
intravascular contrast agent (Brown et al., 2002). This approach has been subsequently
adapted to time-resolved (TR) NIRS to improve its depth sensitivity and used to calibrate
DCS in order to monitor absolute perfusion (Diop, Verdecchia, Lee, & St. Lawrence,
2011). In chapter 2, this NIRS/DCS method was expanded to quantify the cerebral
metabolic rate of oxygen (CMRO2). In chapter 3, the most appropriate flow model for
DCS was investigated by acquired data directly on the brain. Chapter 4 outlined
experiments aimed at assessing a multi-layered (ML) DCS method capable of measuring
CBF through extracerebral tissues comparable in thickness to adults. The individual
advancements in DCS techniques achieved in each chapter will be summarized in this
chapter, and future work to further improve DCS will be discussed. Lastly, the main
conclusions of the thesis will be listed.

5.1 Summary
The main objectives of this thesis focused towards advancing DCS techniques by:
1) Demonstrating an all-optical device that includes DCS is capable of quantifying
CMRO2.
2) Furthering our understanding of the widely accepted diffusion model of flow
applied to DCS.
3) Implementing a multi-layered DCS model to separate flow in extracerebral and
cerebral tissues.
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Outlined in the following subsections is an overview of the progress to DCS methods
made by the three objectives of this work.

5.1.1

Quantification of CMRO2 by an all-optical modality

Monitoring CBF at the bedside would improve patient outcome by detecting reductions
in flow; however, additional monitoring of the metabolic rate would help evaluate tissue
viability since CMRO2 is considered a better indicator of cerebral ischemia than CBF and
oxygenation measurements alone (Powers, Grubb, Darriet, & Raichle, 1985; Tichauer et
al., 2009; Tichauer, Brown, Hadway, Lee, & St. Lawrence, 2006). Diffuse correlation
spectroscopy provides a means to monitor flow changes directly, but it is unable to assess
the tissue metabolic demands. Combining DCS with NIRS has been used to measure
changes in CMRO2 in the developing brain (Roche-Labarbe et al., 2010, 2012), but the
inability of DCS to quantify CBF hinders the all-optical technique from establishing
absolute metabolic thresholds.
Recently, our group demonstrated that the DCS signal can be used to measure
absolute perfusion through calibration with a TR NIRS bolus-tracking method (Diop et
al., 2011). This technique was expanded in Chapter 2 to show that the combination of
DCS with TR NIRS can also measure CMRO2. In this combination, DCS and contrastenhanced NIRS were used to measure CBF, and multi-wavelength TR NIRS was used to
determine the cerebral venous blood oxygenation (SvO2), which was verified by directly
measuring oxygenation in the sagittal sinus. Different cerebral metabolic rates were
induced by altering the anesthetics in newborn pigs. This animal model was chosen since
the scalp and skull are relatively thin and, hence, the optical measurements are principally
from the brain. No significant differences were found between the two sets of SvO2
measurements obtained by TR NIRS and sagittal sinus blood samples. In addition,
Bland–Altman analysis showed a small difference in the corresponding CMRO2 values
(0.027 ± 0.834 mL O2/100g/min) over a range from 0.3 to 4 mL O2/100g/min. This initial
validation study demonstrates that quantitative CMRO2 values can be obtained by a
DCS/NIRS hybrid system.
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5.1.2

Measurements of Relative Blood Flow Changes Directly on
Brain Parenchyma

The normalized temporal intensity autocorrelation function generated by DCS is typically
characterized by assuming that the movement of erythrocytes can be modeled as a
Brownian diffusion-like process instead of by the expected random flow model (Cheung,
Culver, Takahashi, Greenberg, & Yodh, 2001). Most applications of DCS accept the
assumption that Brownian diffusion characterizes moving erythrocytes since this flow
model approximates the computed autocorrelation function well (Durduran & Yodh,
2014). Recently, a hybrid model, referred to as the hydrodynamic diffusion model, was
proposed, which combines the random and Brownian flow models (Carp et al., 2011).
Chapter 3 investigated the most appropriate flow model to describe
autocorrelation functions used to monitor CBF. To avoid confounding effects of
extracerebral tissues, these experiments were conducted with the probes placed directly
on the brain. Relative flow changes were measured by DCS and were analyzed by three
different flow models: random flow, Brownian diffusion, and the combined
hydrodynamic diffusion model. Relative flow changes were verified by computed
tomography perfusion (−39.7 ± 3.7%), of which, only the random flow model was
significantly different (−63.2 ± 4.7%). No significant difference was found compared to
the flow measurements derived using the Brownian and hydrodynamic diffusion models
(-41.0 ± 4.3% and -44.2 ± 5.0 %, respectively). Although the latter provided better
characterization of the autocorrelation functions, the Brownian diffusion model was more
robust and, therefore, it is the most practical model for characterizing DCS data.

5.1.3

Measurements of Relative Blood Flow Changes Through
Thick Extracerebral Tissue

Arguably the greatest challenge with DCS is the influence of superficial tissue on the
detected signal. For simplicity, common DCS techniques assume tissue homogeneity;
however in the adult head, extracerebral tissues, such as scalp and skull, lead to
underestimations of CBF by DCS (Durduran et al., 2004; Gagnon, Selb, & Boas, 2008).
Chapter 4 investigated a ML model that accounts for light propagation in multiple tissue
layers, which was applied to DCS data acquired at multiple source-detector distances.
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First, the ML DCS model was verified in a two-layer diffusion phantom by separating
diffusion in the bottom and top layers. Next, global reductions in CBF (−33.5 ± 4.5 %)
were measured by ML DCS in pigs with an extracerebral tissue thickness similar to
adults (9.8 ± 0.4 mm). For validation, perfusion changes (−36.4 ± 3.3 %) were measured
independently by computed tomography. Bland-Altman analysis determined a mean
difference of -1.2 ± 4.6 % between the two flow modalities, which was bound by a 95%
confidence interval of −31.1 to 28.6 %. This final study demonstrated that reductions in
CBF can be measured accurately by ML DCS in adolescent pigs, which mimic the head
of adults.

5.2 Future Work
5.2.1

Multi-Layered DCS/NIRS Hybrid System

The main focus of the work completed in this thesis was towards advancing and
validating DCS with the long-term goal of using this emerging optical method in
combination with NIRS to monitoring CBF and CMRO2 in critical-care patients. In all
three chapters, tissue optical properties were quantified by TR NIRS and input into the
fitting routine of DCS. For DCS data analysis, the number of fitting parameters were
reduced and, more importantly, the accuracy of the DCS fitting routine improved (Diop
et al., 2011; Irwin et al., 2011). Notably, combining DCS with TR NIRS provides the
ability to monitor both perfusion and CMRO2.
Similar to DCS, TR NIRS is highly sensitive to superficial tissues, which result in
underestimations of CBF (Gora et al., 2002). The excellent temporal resolution due to the
measurement of the time-of-flight of photons by TR NIRS makes it possible to improve
depth sensitivity by time-gating and moment analysis strategies (Diop & St. Lawrence,
2013; Liebert, Wabnitz, & Elster, 2012). A previous colleague demonstrated that multidetector TR NIRS can accurately quantify CBF in a heterogeneous medium (Elliott et al.,
2014; Elliott, 2013). Naturally, similar to Diop et al. (Diop et al., 2011), the next step is to
combine the dissertation work completed by Elliot (2013) with the ML DCS technique
presented in Chapter 4 in order to calibrate changes in CBF in the adult head. This idea
can be expanded by estimating optical properties for separate tissues using a multi-layer
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solution to analyze the TR NIRS data (Liemert & Kienle, 2013). In turn, the cerebral
oxygen saturation could be measured, and therefore, the method presented in Chapter 2
could be used to measure CBF and CMRO2 in the adult head.

5.2.2

Real-Time Data Acquisition

The current NIRS/DCS hybrid device designed for the experiments conducted in this
thesis did not have the capability to provide real-time monitoring. Simultaneous data
acquisition of TR NIRS and DCS is not feasible due to the interplay of detected light, and
alternating manually between optical components is required. A possible solution would
be to automate transitions between NIRS/DCS components but would not allow
simultaneous acquisitions. Installing band-pass filters would make concurrent NIRS and
DCS measurements feasible by removing unnecessary wavelengths at the detection site
of each component. A more challenging approach would be to design a detection system
that utilizes the same components to generate both the autocorrelation functions and the
TPSFs required for DCS and TR NIRS, respectively.
All data analysis in this thesis required post-analysis to compute the respective
physiological parameters. Before transferring the NIRS/DCS system from the laboratory
to the clinic, real-time digitization of measured data is needed. Specific for DCS, the
current data throughput is relatively slow (~1 Hz), which means detected light generates
an autocorrelation curve with sufficient SNR to assess tissue hemodynamics every
second. Work completed in this thesis used few-mode fiber bundles for optimal temporal
resolution of light detection (Dietsche et al., 2007). However for the adult head (Chapter
4), long data acquisition times (~30-60 seconds) were acquired by ML DCS despite
utilizing up to 10 few-mode detection fibers located at the largest source-detector
distance. Future improvements to DCS techniques presented in this thesis would be to
incorporate new innovative methods. For example, converting the correlator board from
the computationally expensive hardware to software would improve the throughput up to
50 Hz, which is fast enough to resolve heartbeat fluctuations (Wang et al., 2016).
Implementing recent innovations with the ML DCS technique presented in Chapter 4 will
increase the speed of blood flow measurements, which may provide real-time perfusion
changes at the bedside of neurocritical adults.

136

5.2.3

Clinical Validation

Pre-clinical experiments simplify optical data collection by lessening potential artifacts,
such to hair and motion; however, in the clinic, these artifacts are difficult to avoid.
Therefore, it is imperative to demonstrate and validate the feasibility of a NIRS/DCS
system at the bedside of patients in clinical trials.
Due to the challenges presented in the clinic, the accuracy and precision of ML
DCS should be investigated and compared to various perfusion imaging modalities,
including positron emission tomography, computed tomography, and magnetic resonance
imaging (arterial spin labeling or phase-contrast). Next, different neurological
emergencies should be assessed to investigate the clinical value of monitoring CBF with
regards to improving the detection and prognosis of delayed cerebral ischemia. Lastly, a
comparison of the success/failure of monitoring changes in CBF by ML DCS with
different management strategies to current clinical care practices would determine the
extent ML DCS fulfills a niche as a noninvasive bedside monitoring device of blood flow
before accepting DCS as a useful bedside management tool in the ICU. The same extent
of clinical trials should be performed to investigate the clinical utility of combining ML
DCS and TR NIRS to quantify CMRO2. Clinical trials, in which, both CBF and CMRO2
is monitored should be completed to understand the relationship during treatment of
neurological emergencies in the ICU to optimize patient outcome.

5.3 Conclusions
With the purpose of assessing cerebral hemodynamics at the bedside, the primary
findings of this thesis advanced DCS by:
1. An all-optical modality, which included combining DCS and TR NIRS,
demonstrated changes in absolute CMRO2 agree well with direct measurements of
blood oxygenation in newborn pigs.
2. Relative flow changes measured by DCS, which was confirmed by computed
tomography, are similar when characterized by Brownian and hydrodynamic
models directly on the exposed cortical tissue in pigs. Although the latter provides a
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better fit to DCS data, the former is more robust deeming it the better model to
characterize flow changes by DCS.
3. Implementation of a multi-layered model to DCS separates flow in extracerebral
and cerebral tissues successfully. Furthermore, the relative changes in CBF
measured by a multi-layered DCS technique were in good agreement with
perfusion changes measured by computed tomography in pigs, which had an
extracerebral tissue thickness of 1 cm.
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